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DISSERTATION ABSTRACT 
 
Ryan Wakefield Holly 
Doctor of Philosophy 
Department of Chemistry and Biochemistry 
March 2020 
Title: Defining the Molecular Mechanisms that Govern Par-3 Mediated Polarization of the 
Par-Complex 
 
Animal cells polarize their membranes into discrete functional domains required 
for a host of cellular processes including asymmetric cell division, epithelial 
morphogenesis, neuronal polarization, and cell migration.  A key regulator of animal cell 
polarity is the protein kinase, atypical Protein Kinase C (aPKC), whose activity is 
required for establishing and maintaining membrane polarity.  While much is known 
about how the activity of aPKC polarizes cells, understanding the molecular mechanisms 
that lead to the regulation and localization of aPKC itself have remained controversial.  
aPKC’s apical localization depends on three additional proteins: Par-6, Par-3, and Cdc42.  
The focus of this work has been to understand the interplay between these proteins that 
lead to polarized aPKC. 
Par-3 is a regulatory substrate thought to directly target aPKC to the membrane.  
The first part of this work argues against a previously held view that Par-3 is an inhibitor 
of aPKC that is not phosphorylated until additional factors activate aPKC kinase activity.  
I clearly demonstrate that aPKC can indeed phosphorylate Par-3 without any additional 
v 
inputs and that catalytic efficiency is similar to other known aPKC substrates.  
Furthermore, I argue that while Par-3 can indeed inhibit aPKC kinase activity, all 
substrates tested can inhibit kinase activity, questioning the physiological consequences 
of Par-3 inhibition of aPKC. 
The second part of this work aims to understand the physical interactions between 
Par-3 and the Par-complex, and how these interactions might contribute to the regulation 
of aPKC.  At least 5 different interactions have been proposed between Par-3 and the Par-
complex.  Surprisingly, in vitro domain deletion analysis revealed that none of the 
previously proposed interactions are required for binding to the fully reconstituted Par-
complex.  However, through this analysis, I uncovered a novel interaction between the 
PDZ2 domain of Par-3 and a conserved aPKC PDZ ligand binding motif (PBM) that is 
required for the apical polarization of aPKC in the Drosophila neuroblast.  Overall, the 
work presented in this dissertation significantly clarifies the controversial mechanisms 
surrounding the interactions between Par-3 and the Par-complex while defining a novel 
physical connection that links Par-3 to the Par-complex. 
This dissertation includes previously published co-authored material. 
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CHAPTER I 
REGULATION AND LOCALIZATION OF THE PAR-COMPLEX IN ANIMAL 
CELL POLARITY 
 
Chapter II contains previously published co-authored material 
Chapter III contains previously published co-authored material 
 
INTRODUCTION 
The segregation of cellular components such as proteins, lipids, organelles, and 
small molecules into discrete regions of the cell is important for diverse cellular 
processes such as, epithelial morphogenesis, asymmetric cell division (ACD), 
embryogenesis, neuronal signaling, and cell migration (Figure 1) (Goldstein and Macara, 
2007).  This process, known as animal cell polarity, is used to create cellular diversity, 
tissue organization, and to provide domain specific functions required of specialized cells 
(Apodaca and Gallo, 2013).  Epithelia are a great example of a polarized cell whose 
function is to form sheets of adherent cells, lining organs with a protective barrier against 
the external environment.  Proper segregation of the epithelial membrane into distinct 
apical, basal-lateral, and junctional domains is required for development, and loss of this 
polarity leads to gross morphological defects in the organism (Harris and Peifer, 2005; 
Hutterer et al., 2003; Tepass et al., 2001; Wodarz et al., 2000; Yamanaka et al., 2001).   
Another example of a polarized cell is the Drosophila melanogaster neuroblast 
(neural stem cells), which segregate specific sets of proteins known as fate determinants 
into opposite poles of the cell (Figure 2).  Throughout the process of asymmetric cell 
 
 
 
2 
division (ACD), each post-mitotic daughter cell will contain a unique set of fate 
determinants necessary to generate two different daughter cells varying in their fate.  One 
daughter will become an exact replicate of the original neuroblast while the other 
daughter will give rise to a ganglion mother cell (GMC) that undergoes one more round 
of division, populating the central nervous system with neurons and glia (Prehoda, 2009).  
A similar process of asymmetric cells division is found in the C. elegans zygote where 
sperm derived cues induce the segregation of fate determinants required to specify cell 
type (Kemphues et al., 1988).   
 
 
Figure 1: Animal cell polarity is found in diverse cell types.  Animal cells polarize their 
membranes into discrete apical (purple) and basal/basal lateral (orange) domains for a variety 
of specialized functions.  (A) Neural stem cell (neuroblast) with budding GMC’s.  (B) C. 
elegans zygote at the single cell stage.  (C) Neuron.  (D) Epithelial cell with junctions (red). 
(E) Migratory Cell.   
Migration
A B C
D E
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Remarkably, while the functional output of animal cell polarity varies 
considerably between polarized cells, the mechanisms that underly the establishment and 
maintenance of cell polarity are highly conserved.  In general, regulators of cell polarity 
are restricted to their respective apical and basal cortical domains, where they exert their 
activity to establish polarity gradients through mutual antagonism (Prehoda, 2009; 
Tepass, 2012).  A key regulator of cell polarity is the protein kinase, atypical Protein 
Kinase C (aPKC).  Many polarized metazoan cells utilize the activity of aPKC to 
establish and maintain a strict apical-basal cortical gradient. 
 
In neuroblasts, the activity of aPKC is required to set up an apical/basal gradient 
where aPKC is retained at the apical cortex, restricting fate determinants like Miranda 
(Mira) and Numb to the basal cortex through phosphorylation mediated cortical 
displacement (Figure 3) (Atwood and Prehoda, 2009; Betschinger et al., 2003; Hurov et 
al., 2004; Smith et al., 2007; Wirtz-Peitz et al., 2008).  During interphase of the mitotic 
 
 
Figure 2: Asymmetric cell division in neural stem cells.  Neural stem cells (neuroblasts) 
divide asymmetrically giving rise to two molecularly distinct daughter cells.  One daughter 
will self-renew becoming an exact replica of the original neuroblast while the other will 
become a ganglion mother cell (GMS) undergoing one more round of division populating the 
central nervous system with Neurons and glia. 
Neuroblast
Self-renewed
Neuroblast
GMC
Apical
Basal
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cell cycle, Mira and Numb can freely diffuse throughout the cortex while aPKC is 
inactive and cytoplasmic (Figure 4).  As the cell moves into prophase, aPKC begins to 
form discrete puncta that grow in size, eventually coalescing at metaphase into one 
homogeneous patch to form an apical cap (Oon and Prehoda, 2019).  Polarized aPKC 
uses its activity to phosphorylate the fate determinants Numb and Mira at multiple basic 
and hydrophobic motifs that inhibit their association with the negatively charged lipid 
environment of the cell cortex, restricting their localization to the basal cortical domain 
(Bailey and Prehoda, 2015).  aPKC’s activity remains polarized throughout metaphase 
and depolarizes during telophase, at which point aPKC is lost to the cytoplasm and the 
cycle repeats (Oon and Prehoda, 2019).  
  
 
 
 
Figure 3: Phosphorylation mediated cortical displacement.  aPKC phosphorylation of fate 
determinants like Miranda (Mira) inhibits their interaction with the cell cortex, restricting 
them to the basal domain.  
Mira
aPKC
Mira
Mira
Mira
P
 
 
 
5 
The diversity of polarized cells that require aPKC to establish polarity gradients is 
remarkable.  Common to all aPKC polarized cells is the need to regulate the spatial and 
temporal activity of aPKC such that it is only active when localized to the apical cortical 
domain.  The regulation of aPKC depends on both intra-molecular interactions with its 
NH2-terminal regulatory domains as well as interactions with Par-6, Cdc42, and Par-3 
(Etienne-Manneville and Hall, 2002; Graybill et al., 2012; Horikoshi et al., 2009; Nagai‐
Tamai et al., 2002; Suzuki, 2006; Yamanaka et al., 2001; Zhang et al., 2014).  Together 
with aPKC these four proteins form the basis of the apical polarity network and are 
required for the proper establishment and maintenance of animal cell polarity. 
 
 
Figure 4:  Localization of aPKC and Miranda throughout the D. Melanogaster 
neuroblast cell cycle.  At interphase aPKC starts out cytoplasmic, moving to the entire cortex 
in prophase.  By metaphase, aPKC is polarized to the apical cap.  By telophase, aPKC is 
absent from budding GMC.  Following cleavage, aPKC dissociates from the membrane into 
the cytoplasm where the cycle repeats. 
 
Interphase
Cytoplasmic
aPKC
Prophase
Cortical
aPKC
Polarized
aPKC
Metaphase
Telophase
Budding
GMC
aPKC
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aPKC and the apical polarity network 
aPKC is a potent serine/threonine kinase whose activity must be tightly regulated.  
Removing any component of its regulation has dramatic effects on cell polarity.  For 
example, in the Drosophila neuroblast, depolarization of aPKC activity through a 
mutation that drives it to the entire cortex throughout the cell cycle, gives rise to 
symmetrically dividing neuroblasts (Wirtz-Peitz et al., 2008). Bypassing the regulation of 
aPKC activity and localization allows aPKC to inhibit all cortical Mira leading to over 
proliferation of neuroblasts and tumor formation in the central brain.  While the catalytic 
activity of aPKC is responsible for phosphorylation of substrates, its activation and 
localization are regulated by its NH2-terminal regulatory domains and interactions with 
several important Par-polarity proteins: Par-6, Cdc42, and Par-3.  In the following 
sections I will give a general overview of protein kinases, discuss the importance of the 
aPKC NH2-terminal regulatory domains, and the reported mechanisms of aPKC 
regulation by Par-6 and Cdc42. 
 
Protein Kinases: Regulators of cellular processes 
Protein phosphorylation by kinases is an essential process necessary for proper 
cellular signaling events such as activation or inhibition of enzymes and proper 
localization of targeted substrates (Endicott et al., 2012).  Currently there are over 500 
kinases that make up the human kinome representing nearly 2% of the human genome 
(Taylor and Kornev, 2011).  Kinases can be loosely divided into two broad categories, 
those that phosphorylate serine or threonine residues and those that phosphorylate 
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tyrosine.  Both Ser/Thr and Tyr kinases share similar sequence homology within the ~290 
amino acid catalytic core that makes up the kinase domain.   
Catalytically active kinases share similar structural features, however, in their 
inactive form structure diverges significantly (Endicott et al., 2012; Jura et al., 2011; 
Noble et al., 2004).  The active conformation of kinases requires the proper alignment of 
the N and C lobes as well as the regulatory and catalytic spines in order to allow for both 
ATP binding and to form the catalytically competent active site for proper 
phosphorylation of substrates (Figure 5).  Additionally, the active conformation of 
 
 
Figure 5: Crystal structure of aPKC𝜄 in complex with Par-3 peptide.  Crystal structure of 
aPKC𝜄 highlighting important structural features.  N-lobe (purple), C-lobe (orange), 
Regulatory segment (gray), 𝛂C-Helix (Red), Activation Loop (Teal), Substrate (Green). 
PDB:4DC2. 
Regulatory 
Segmant
N-Lobe
њC-Helix
C-Lobe
Activation 
Loop
T412
T560
DFG
Motif
ATP
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kinases requires the presence of Mg2+ ions that are chelated through the highly conserved 
DFG motif that allows for ATP binding necessary for transfer of the gamma phosphate to 
the substrate.  In the inactive conformation, the aspartic acid residue from the DFG motif 
is positioned into the ATP binding pocket inhibiting the ability of ATP to bind.  While 
the active forms of kinases are structurally and functionally similar, how kinases 
transition from an inactive to active conformation is highly variable.  Molecular 
mechanisms for such activation include phosphorylation, active site substrate specificity, 
transcriptional regulatory control, dimerization, substrate availability, and autoinhibition 
through intramolecular interactions from flanking regulatory domains (Bayliss et al., 
2015; Endicott et al., 2012; Nolen et al., 2004).  Additionally, kinases can be regulated 
through repression of auto-inhibitory segments by intermolecular interactions with 
activator proteins or small molecules (Graybill et al., 2012; Orr et al., 1992).  How 
kinases undergo such regulation and specificity leading to spatial and temporal 
activation/inactivation has become increasingly important in understanding biological 
processes.  Additionally, due to their significant role in signal transduction pathways, 
kinases have become desirable drug targets for a multitude of disease states. 
 
Multimodal activation of aPKC allows for precise spatial and temporal activation 
The Protein Kinase C (PKC) family of kinases includes 12 homologues which are 
identified as conventional (cPKC), novel (nPKC), or atypical (aPKC) based on their 
flanking regulatory domains (Pearce et al., 2010).  There are a number of important 
features that differentiate aPKC from cPKCs and nPKCs, most notably the NH2-terminal 
regulatory domains (Figure 6).   
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A considerable amount of effort has been put into understanding the mechanism 
of activation for conventional PKCs especially with respect to the maturation of the 
catalytic core (Bayliss et al., 2015; Dutil and Newton, 2000; Gao and Newton, 2006; 
Tepass, 2012; Yamanaka et al., 2001)  PKCs initially undergo post-translational 
phosphorylation of 2 (aPKC) or 3 (cPKC, nPKC) residues within the kinase domain, 
(Dutil and Newton, 2000) which allows for the proper alignment of the N- and C- lobes 
as well as the regulatory and catalytic spines, leading to a catalytically competent kinase 
domain.  However, following phosphorylation PKCs become inactivated through the 
interactions with their NH2-terminal regulatory domains.  This unique multimodal 
activation of PKCs allows them to be ubiquitously expressed and catalytically competent 
and inactive such that their activity can be further regulated by cell specific mechanisms.  
Unlike cPKC’s and nPKC’s whose lipid binding and activity is dependent on the binding 
to diacylglycerols or phorbol esters through their C1 domains, aPKC has an “atypical” C1 
domain that does not depend on these small molecules for lipid binding (Colongonzalez 
and Kazanietz, 2006; Giorgione et al., 2006, 2006).  The C1 domain of aPKC will be 
 
 
Figure 6: PKC’s vary in their NH2-terminal regulatory domains.  Comparison of domain 
architecture of conventional (cPKC), novel (nPKC) and atypical (aPKC) PKC’s. 
PB1 C1 Protein Kinase
PS
aPKC
Protein Kinase
PS
C2 C1A C1BnPKC
Protein Kinase
PS
C2C1A C1BcPKC
Catalytic DomainRegulatory Domain
 
 
 
10 
discussed in more detail below.  Additionally, aPKC’s are the only PKC family members 
that contain a PB1 domain, and as will be discussed in the next section, plays a critical 
role in the apical polarization of aPKC. 
 
The Par-complex and the role of Par-6 and Cdc42 in regulating aPKC activity and 
localization 
The NH2-terminal regulatory region of aPKC is comprised of several important 
and highly conserved domains (Figure 7).  The Phox/Bem1 (PB1) domain is required for 
binding to the PB1 domain of the adaptor protein Par-6 through high affinity PB1 
heterodimerization and this interaction is required for both localization and activation 
(Graybill et al., 2012; Hirano et al., 2005).  Inhibition of this interaction gives rise to 
cytoplasmic aPKC that is inactive while Mira is depolarized, localizing to the entire 
cortex.  Together, aPKC and Par-6 form what I will refer to as the Par-complex (Figure 
7).  COOH-terminal to the aPKC PB1 is a pseudosubstrate (PS) sequence that is similar 
to aPKC’s consensus sequence but lacks a phosphorylatable serine or threonine residue.  
The PS binds in the catalytic cleft of the kinase domain, acting as a competitive inhibitor 
giving rise to a catalytically competent, yet inactive aPKC.  Par-6 binding represses auto-
 
 
Figure 7:  Domain architecture of aPKC and Par-6.  Together aPKC and Par-6 form the 
Par-complex.  Abbreviations:  PBM – PDZ binding Motif.  PS – Pseudosubstrate.  
PB1 C1 Protein Kinase
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aPKC
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CRIB
PDZPar-6
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inhibition by the PS, thus providing a regulatory mechanism for aPKC’s kinase activity 
(Graybill et al., 2012).  Immediately following the PS is a conserved C1 domain that 
contains a general lipid binding motif.  The C1 domain is required for aPKC’s association 
with the cortex and is itself sufficient to bind the cortex, however the C1 alone is not 
sufficient to drive aPKC to the cortex suggesting some form of regulation of its lipid 
binding motif.  How or if the C1 domain is regulated is still unknown.  One hypothesis is 
that the C1 domain is autoinhibited and due to the close proximity of the PS to the C1, 
may couple repression of PS autoinhibition to C1 activation leading to an active aPKC 
while only localized at the lipid membrane.  Early studies have shown that phospholipids 
can in fact activate aPKC, lending further support to this hypothesis (Johnson et al., 2000; 
Newton, 1997). 
As mentioned above, Par-6 contains a PB1 domain that allows for high affinity 
binding to aPKC through PB1 heterodimerization.  COOH-terminal to the PB1, Par-6 
contains a semi-CRIB domain directly followed by a PDZ domain (Figure 7).  The semi-
CRIB is an important feature of Par-6 providing a direct link between aPKC and the 
membrane tethered small GTPase, Cdc42 (Joberty et al., 2000; Lin et al., 2000).  
Furthermore, when Par-6 is bound to the active form of Cdc42, it induces a 
conformational change in the PDZ domain, increasing its affinity for COOH-terminal 
PDZ ligand Binding Motifs (PBM) by 10 – 20 fold (Peterson et al., 2004; Whitney et al., 
2011, 2016).  In epithelia, the transmembrane protein Crumbs has a PBM whose binding 
to the Par-complex is regulated by Cdc42 (Whitney et al., 2016).  Interestingly, no 
PBM’s have been identified in neuroblasts that interact with the Par-6 PDZ domain and 
as such, the role of the Par-6 PDZ domain is largely unknown in this system.  However, 
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as will be discussed later in detail, the PDZ domain of Par-6 has been shown to interact 
with Par-3 through a non-conventional and controversial mechanism. 
Cdc42 is a GTPase whose activity is dependent on its nucleotide state.   Cdc42 is 
conserved throughout eukaryotes from yeast to humans and plays a significant role in 
numerous cell processes including cytoskeletal dynamics, membrane trafficking, and 
animal cell polarity (Chant, 1999; Leibfried et al., 2013; Zegers and Friedl, 2014).  
Guanine Nucleotide Exchange Factors (GEFs) are required to activate Cdc42 by 
promoting exchange between an inactive GDP bound conformation, and an active GTP 
bound conformation.  GTPase-activating proteins (GAPs) inactivate Cdc42 by promoting 
the hydrolysis of GTP (Cherfils and Zeghouf, 2013; Ngok et al., 2014).  The interplay 
between GEF’s and GAP’s is critical for the regulation of Cdc42 activity and it has been 
shown that their activity is also polarized (Lang and Munro, 2017).  Cdc42 is tethered to 
the cell cortex through a prenylation modification and this in turn allows for the direct 
tethering of the Par-complex to the cell cortex, mediated by Par-6 (Zhou et al., 2013).  
While Cdc42 localizes to the entire cortex, its activity is polarized, thus ensuring apical 
polarization of the Par-complex (Nunes de Almeida et al., 2019; Wang et al., 2017). For 
example, in WT neuroblasts the Par-complex co-localizes with Cdc42 at the apical 
domain, however, cells overexpressing a constitutively active form of Cdc42 that drives 
active Cdc42 to the entire cortex leads to cortical localization of the Par-complex and a 
depolarized cell.  While Par-6 and Cdc42 along with the C1 domain would seem to be 
sufficient to drive aPKC polarization, the PDZ scaffold protein, Par-3 is also required. 
 
 
 
 
 
13 
The role of Par-3 in regulating aPKC activity and localization 
Par-3 is a large multi-PDZ domain scaffold protein comprised of an NH2-terminal 
oligomerization domain that is required for membrane localization, a series of 3 PDZ 
domains, and an aPKC phosphorylation motif (APM) (Figure 8) (Feng et al., 2007; Li et 
al., 2010a; Nagai‐Tamai et al., 2002; Wu et al., 2007).  Par-3 is required for the apical 
recruitment and retention of aPKC, Par-6, and Cdc42, while its localization, is 
independent of these other proteins, establishing Par-3 as the most upstream component 
of the apical polarity network (Atwood et al., 2007; Morais-de-Sá et al., 2010).  Par-3 
was originally discovered in a landmark genetic screen for mutants that gave rise to 
partitioning defects in the C. elegans embryo (Kemphues et al., 1988).  Nearly a decade 
later, Par-3 was first characterized when it was found to interact with aPKC’s catalytic 
domain through a highly conserved region in the COOH-tail, and this interaction was 
shown to be required for polarity in both epithelia and the C. elegans zygote (Izumi et al., 
1998; Tabuse et al., 1998).  Since that time no less than 5 distinct interactions have been 
 
 
Figure 8:  Par-3 interacts with aPKC and Par-6.  All previously reported binding 
interactions between aPKC, Par-6, and Par-3.  Abbreviations: APM – aPKC Phosphorylation 
Motif.  PBM – PDZ Binding Motif.  PS – Pseudosubstrate.  OD – Oligomerization Domain. 
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identified between aPKC, Par-6, and Par-3 (Joberty et al., 2000; Kemphues et al., 1988; 
Lin et al., 2000; Nagai‐Tamai et al., 2002; Renschler et al., 2018; Soriano et al., 2016; 
Tabuse et al., 1998; Wodarz et al., 2000).  In this section I will discuss what is currently 
known about Par-3, how it interacts with the Par-complex, and what this means for its 
regulation and localization of aPKC activity. 
 
Localization of Par-3 is dynamic 
 Par-3 localization to the cortex initially depends on a number of factors including 
oligomerization through its OD, association with membrane lipids, and its interaction 
with other proteins (Feng et al., 2007, 2007; Wu et al., 2007).  Interestingly, in many cell 
types including neuroblasts, epithelia, and the C. elegans zygote, polarization of Par-3 
does not depend on the Par-complex.  In epithelia, while apical localization does not 
depend on the Par-complex, its subsequent junctional association does (Morais-de-Sá et 
al., 2010).  In asymmetrically dividing cells such as the C. elegans zygote, Par-3 initially 
localizes to the posterior, where it forms puncta that strongly co-localize with the Par-
complex as cortical flows move it towards the anterior pole (Rodriguez et al., 2017; 
Wang et al., 2017).  The OD is critical for Par-3 localization to the cortex where self-
oligomerization increases the lipid binding affinity to the cortex (Dickinson et al., 2017; 
Feng et al., 2007; Li et al., 2010a).  Disruption of the oligomerization domain 
significantly diminishes cortical puncta (Dickinson et al., 2017).  Throughout the cell 
cycle, Par-3/Par-complex puncta coalesce to form an apical cap much like the 
localization of aPKC observed in Drosophila neuroblasts (Oon and Prehoda, 2019; 
Rodriguez et al., 2017).  These observations along with the fact that Par-3 is required for 
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Par-complex polarization, have led to models where Par-3 forms a stable inhibited 
interaction with the Par-complex, and that this complex assembly is crucial for the 
regulation and polarization of aPKC activity (Rodriguez et al., 2017).  How Par-3 
polarizes the Par-complex and why Par-3 is necessary, considering Cdc42 would seem to 
be sufficient to drive Par-complex polarization, has led to complex and often 
controversial models.     
 
The Par-3 aPKC phosphorylation motif regulates aPKC activity through a stable and 
inhibited complex. 
 Par-3 was initially reported to interact with aPKC through a region COOH-
terminal to the PDZ domains and this interaction was shown to facilitate the proper 
polarization of cells by localizing aPKC to the apical domain (Izumi et al., 1998; Nagai‐
Tamai et al., 2002).   This region was shown to bind with “high affinity” to the kinase 
domain of aPKC and to contain a serine residue that is phosphorylated both in vitro and 
in vivo (Nagai‐Tamai et al., 2002).  Interestingly, the authors concluded that this was a 
regulatory mechanism to dissociate Par-3 from aPKC.  It is important to note that this is a 
general mechanism of all kinases where phosphorylation of its substrate destabilizes the 
interaction with the kinase.  As such, this does not seem to be a regulatory mechanism 
unless activity of the kinase were to be regulated or the phosphorylation event was 
allosterically regulating another interaction.  Neither of these were shown as the C-tail 
was is indeed phosphorylated and independent of any activating steps.  This was the first 
instance of Par-3 mediated regulation of aPKC activity that has led to models that suggest 
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Par-3 can form a stable inhibited complex with aPKC through what is normally thought 
of as a transient enzyme/substrate interaction.   
More recently it has been reported that the human Par-3 APM binds to the 
catalytic site of aPKC’s kinase domain with high affinity and does not get 
phosphorylated.  This was a very surprising result as it had been previously shown that 
the mammalian, fly, and worm Par-3 could all be phosphorylated by aPKC (Li et al., 
2010a; Lin et al., 2000; Morais-de-Sá et al., 2010; Nagai‐Tamai et al., 2002).  
Importantly, all of these studies used radiolabeled ATP to show the direct 
phosphorylation of Par-3, whereas Soriano et al used a less sensitive indirect method to 
detect the release of ADP (Soriano et al., 2016).   These observations led the authors to 
conclude that Par-3 forms a stable inhibited interaction with aPKC and that something 
else must happen to activate aPKC in order to phosphorylate Par-3 and release it from the 
complex (Soriano et al., 2016).   
This ability of aPKC to have different levels of activation depending on the 
substrate has certainly led to some confusion, perpetuated by the fact that an activating 
factor has yet to be identified.  Furthermore, this interaction was suggested to play an 
inhibitory role, defining a new class of aPKC substrates as inhibitor substrates that are 
unique from classical substrates.  While this is an intriguing model for how Par-3 could 
both polarize and regulate aPKC activity, it directly contradicts previous in vivo studies 
that suggest Par-3 positively regulates aPKC activity (Achilleos et al., 2010; McCaffrey 
and Macara, 2009; Wirtz-Peitz et al., 2008).   For example, over-expression of Par-3 in 
Drosophila leads to the over proliferation of neuroblasts, indicative of over-active aPKC 
(Wirtz-Peitz et al., 2008).  Expression of a phosphomimetic Par-3 in Drosophila epithelia 
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leads to constricted membranes, however, Lgl is still polarized, indicating aPKC is active 
(Morais-de-Sá et al., 2010).  Recently, Rodriguez et al developed an inducible reporter 
assay to target aPKC to the C. elegans embryo cortical domain in the presence of PMA 
(Rodriguez et al., 2017).  In the absence of PMA, aPKC was cytoplasmic and the 
posteriorly localized Par-2 was cortical.  In WT cells, PMA induced aPKC to the cortex, 
clearing Par-2.  However, under Par-3 RNAi conditions, aPKC failed to clear Par-2 from 
the membrane.  This led the authors to conclude that there is a functional consequence for 
Par-3 inhibition of aPKC, apparently reconciling this controversy between in vivo and in 
vitro data.   
It is fascinating that these two studies by Soriano et al. and Rodriguez et al. have 
redefined our current understanding of the role of Par-3 in regulating aPKC activity, 
contradicting all other functional evidence that suggests otherwise.  This new model now 
suggests that Par-3 forms a functionally distinct inhibited state that is required for the 
proper regulation of aPKC activity and polarization.  In chapter II I revisit the role of Par-
3 inhibition and show that Par-3’s APM is not unique to any other aPKC substrate and 
that it is indeed phosphorylated by aPKC regardless of activating factors. Furthermore, 
consistent with first principles of enzyme kinetics, all substrates can compete with other 
substrates for access to the kinase active site and thus “inhibitor substrates” are just 
substrates. 
 
Binding interactions between the Par-complex and the Par-3 PDZ domains. 
 In addition to Par-3’s interaction with aPKC through its APM, at least 4 additional 
interactions have been reported between Par-3 and the Par-complex (Figure 8).  Initially 
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it was shown that the Par-3 PDZ1 domain could interact directly with the PDZ domain of 
Par-6 (Joberty et al., 2000; Lin et al., 2000; Morais-de-Sá et al., 2010).  It was speculated 
that this interaction occurred through a process of PDZ stacking which occurs between 
the PDZ domain of neuronal nitric oxide synthase (nNos) and the PDZ domain of 
syntrophin (Hillier et al., 1999).  Here, a 𝛽-finger from nNos acts as a COOH-terminal 
peptide, binding into the ligand binding groove of syntrophin.  Unlike this example, there 
is little evidence to suggest that Par-3 PDZ1 binds to Par-6 PDZ domain in a similar 
fashion.  Furthermore, two decades have passed since this initial discovery by two 
independent groups, yet the regulation of this interaction is still unknown.  The 
importance of this interaction has been controversial since its initial discovery.  For 
example, co-expression of Par-3 lacking the APM and Par-6 fail to co-immuno-
precipitate in COS cells (Nagai‐Tamai et al., 2002).  More recently it was shown by 
NMR that neither D. Melanogaster nor C. elegans PDZ1 directly interact with Par-6 PDZ 
domain calling into question the relevance of this interaction (Renschler et al., 2018).  
Furthermore, there is no genetic evidence to suggest that Par-3 PDZ1 is required for its 
interaction with the Par-complex.  In fact, in C. elegans it was shown that Par-3 mutants 
that lacked the PDZ1 domain could rescue the Par-3 null mutant phenotype (Li et al., 
2010a). 
 More recently, Par-6 was shown to interact with Par-3’s PDZ1 and PDZ3 
domains through a novel Par-6 PBM (Renschler et al., 2018).  The affinities of the PDZ1 
and PDZ3 for Par-6 PBM were quite low (216 µM and 54 µM respectively), however 
binding avidity with other previously reported interactions may strengthen these 
relatively weak interactions.  Furthermore, the PDZ1 and PDZ3 may work redundantly 
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allowing for the binding of two Par-complex molecules for each Par-3.  In combination 
with the OD, this would allow for the formation of large oligomeric complexes shown to 
be important for Par-complex polarization (Dickinson et al., 2017).  However, the 
physiological relevance of the Par-6 PBM is questionable.  Deletion of the Par-6 PBM on 
Par-6 apical localization in Drosophila epithelia alone was not statistically significant 
when compared with WT whereas deletion of the PDZ domain alone was (Renschler et 
al., 2018).  Interestingly, deletion of both the PDZ and the PBM increased the mis-
localization of Par-6 when compared with the deletion of the PDZ alone leading the 
authors to conclude that the PDZ and the PBM are redundant. 
 Finally, a Yeast-2-Hybrid screen was used to show that the Par-3 PDZ2-PDZ3 
could interact with aPKC but could not interact with either domain alone (Wodarz et al., 
2000).  Unfortunately, the consequences of these mutations were not assessed in vivo.  In 
chapter III I investigate the interactions between Par-3 and the highly purified and 
reconstituted Par-complex, re-defining the molecular mechanisms that lead to complex 
formation. 
 
Knowledge Gap: The complex and controversial nature of Par-3’s interaction with 
the Par-complex. 
 With no less than five distinct interactions between Par-3 and the Par-complex, 
the mechanisms that lead to aPKC regulation and complex assembly are no doubt 
controversial.  Furthermore, one of these interactions is an enzyme/substrate interaction 
that is normally thought of as transient yet has been proposed to be a regulated interaction 
that inhibits aPKC activity, requiring additional inputs for phosphorylation.  
20 
Complicating the issue is that in no context that we are aware of has it been demonstrated 
that any of the proposed interactions are required for the regulation of Par-complex 
activity or apical polarization in vivo.  It is certainly possible that the lack of a phenotype 
is due to redundancy between all of these interactions, and only when you remove all 
possible interactions (such as a Par-3 null) do you get the expected phenotype.  Further 
complicating this issue is that PDZ domains are promiscuous and may serve multiple 
functions.  For example, the PDZ2 domain has been shown to bind to PIP lipids while the 
PDZ3 interacts with the lipid phosphatase, PTEN (Wu et al., 2007).  Additionally, these 
interactions may have different roles depending on the cellular context.  This does raise 
an interesting question regarding the necessity of having all of these interactions and if all 
of these interactions are required, what regulates them.  For Par-3 to act to recruit the Par-
complex to the apical domain, it must form a stable complex whose binding is regulated.  
The current models suggest that Par-3 forms a stable interaction with the Par-complex 
through an inhibited enzyme/substrate interaction and something else must happen to 
activate Par-3 phosphorylation and subsequent dissociation of the Par-complex (Lang and 
Munro, 2017; Wen and Zhang, 2018).  Furthermore, it has been speculated that Cdc42 
and Par-3 are mutually exclusive in their interaction with the Par-complex and that Cdc42 
may activate aPKC’s activity (Rodriguez et al., 2017).  This is an attractive model, where 
Par-3 recruits an inactive stable complex until it is positioned at the apical membrane 
where active Cdc42 binding allows for the phosphorylation and dissociation of Par-3 
from the Par-complex. 
A caveat to all previously identified binding interactions is that these were all 
studied in the context of individual domains and as such it is difficult to determine the 
 
 
 
21 
requirements of these interactions for complex formation.  Additionally, working with 
individual domains limits the ability to look at redundancy or cooperation between 
binding interactions.  In order to bring clarity to these controversial issues as well as 
begin to fully understand the regulatory role of Par-3 on the Par-complex, I have 
addressed two main questions: 
1. Is Par-3 unique to other aPKC substrates in that its APM inhibits kinase 
activity until additional factors fully activate aPKC? 
2. What binding interactions are required for complex formation between Par-6, 
aPKC, and Par-3? 
The answers to these questions will help further our understanding of the molecular 
mechanisms that govern complex formation between Par-3 and the Par-complex, with the 
ultimate goal in understanding the complex mechanisms that lead to the regulation of 
aPKC.   
aPKC is polarized by Par-3 and Cdc42 in diverse and specialized cells.  Are the 
mechanisms of aPKC regulation conserved in different cell types?  While regulation of 
the intricate interplay between aPKC, Par-6, Par-3 and Cdc42 may vary, the underlying 
molecular mechanisms that govern the interactions between these four proteins may not.  
Therefore, defining the requirements for complex formation is paramount to our 
understanding of aPKC regulation and more generally how cells polarize throughout the 
metazoan landscape. 
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Bridge to Chapter II  
 In this chapter I have given an overview of the apical polarity network, including 
the key players that are all required for the proper polarization of cells with special 
attention to Par-3’s role in Par-complex polarization.  Additionally, I reflected on the 
controversial nature surrounding Par-3’s role in regulating Par-complex activity and 
polarization.  In the following chapter I will argue that the Par-3 APM binding to the 
kinase domain is a transient interaction, like all enzyme/substrate interactions, and thus 
does not support a mechanism for the stable recruitment of the Par-complex to the apical 
membrane.  This study clearly demonstrates that Par-3’s APM is in fact phosphorylated 
in the absence of any additional inputs.  Furthermore, I show that while Par-3 can inhibit 
aPKC activity, this is not unique to Par-3 as all substrates can inhibit kinase activity as is 
consistent with first principles. 
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CHAPTER II 
PHOSPHORYLATION OF PAR-3 BY ATYPICAL PROTEIN KINASE C AND 
COMPETITION BETWEEN ITS SUBSTRATES 
 
*This chapter contains previously published co-authored material. 
 
Holly, R.W., Prehoda, K.E. (2019) Phosphorylation of Par-3 by Atypical Protein Kinase 
C and Competition Between its Substrates. Dev Cell 49 (5), 678-679  
 
Author contributions: R.H performed all the experimental work.  K.E.P and RH were 
both involved in the experimental design.  K.E.P and R.H wrote the manuscript.  K.E.P 
directed the program 
 
Phosphorylation of the polarity protein Par-3 by atypical Protein Kinase C 
(aPKC) has been observed for the fly (Morais-de-Sá et al., 2010), worm (Li et al., 2010a), 
and mouse (Lin et al., 2000) proteins and is important for epithelial polarity (Tepass, 
2012). Recently Soriano et al. failed to observe phosphorylation of human Par-3 (Soriano 
et al., 2016), which led them to conclude that Par-3 forms a stable complex with aPKC 
(inhibiting phosphorylation of other substrates) and is not phosphorylated and released 
until an unknown activating step occurs. However, they used an assay that detects ADP 
product that is relatively insensitive compared to the standard radioactive protein product 
assay used in previous studies. Here, we use the more sensitive assay to examine aPKC’s 
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phosphorylation of human Par-3 and other substrates, and to measure how well aPKC 
substrates compete with each other for aPKC’s catalytic activity.  
We readily detected phosphorylation of human Par-3 by the human aPKC kinase 
domain, both for the Par-3 peptide used in the original study (provided by the authors; 
Figure 9A) and for an MBP fusion of Par-3’s aPKC recognition sequence, known as CR3 
(Figure 9B). We also determined the kinetic parameters kcat and KM for aPKC 
phosphorylation of human and fly Par-3, and several other substrates. We found that 
while the maximal rate constant for human CR3 phosphorylation (kcat) is relatively low 
compared to some other aPKC substrates (Figure 9C), it is higher than kcat for many other 
enzyme-substrates (Bar-Even et al., 2011). Furthermore, the phosphorylation activity of 
human Par-3 is similar to fly Par-3 and other aPKC substrates in terms of catalytic 
efficiency (kcat/KM), a standard measure of substrate quality (Figure 9C). Thus, no 
activation step is required for the human Par-3 CR3 sequence to be phosphorylated by the 
human aPKC kinase domain. 
Soriano et al. also concluded that the human Par-3 CR3 specifically inhibits the 
aPKC kinase domain and defined two classes of substrates, “substrates” (those that are 
unable to inhibit) and “inhibitor substrates” (those that can). It is important to note that all 
substrates compete with each other for access to the active site (Fersht, 1999). However, 
Soriano et al. concluded that inhibition of aPKC is specific to Par-3 because they 
observed that another aPKC substrate, Par-1, does not inhibit: “In contrast, peptides from 
other known aPKC substrates such as Par1 were efficiently phosphorylated and were 
unable to inhibit”. However, the Par-1 inhibition data were omitted from the paper, and 
furthermore they detected inhibition by monitoring the amount of ADP produced when a 
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model substrate was phosphorylated and the candidate “inhibitor” is increased in 
concentration (Figure 9D), and this assay is susceptible to false negatives (i.e. indicating 
a substrate doesn’t inhibit when it does). This is due to the inability of the ADP assay to 
distinguish between phosphorylation of the model substrate and candidate inhibitor 
(phosphorylation of either produces ADP; Figure 9E). To determine whether substrates 
other than Par-3 inhibit aPKC we monitored phosphorylation of the model substrate used 
by Soriano et al. using the radioactive protein product assay, which does not have this 
limitation. All substrates tested, including Par-1 and Numb, inhibited aPKC 
phosphorylation of the model substrate, although with varying efficiencies (Figure 9F, 
G). We also found that Par-1 inhibited phosphorylation of Par-3 (Figure 9H). Thus, we 
do not believe division of aPKC substrates into two categories – those that are able to 
inhibit phosphorylation other substrates, and those that are unable – is useful because the 
latter category doesn’t exist: all substrates compete with one another for access to the 
active site. 
Soriano et al. also concluded that Par-3 CR3 inhibition of aPKC is functionally important 
based on experiments assessing the effect of fly Par-3 (aka Bazooka; Baz) CR3 mutations 
on epithelial polarity. The authors assumed that the CR3 mutations solely affected Par-
3’s ability to inhibit aPKC’s phosphorylation of other substrates, but we note that the 
recognition sequence within a protein kinase substrate plays at least two roles, mediating 
binding to the kinase’s active site so the substrate can be phosphorylated, and interacting 
with downstream components, in addition to any putative role in inhibiting the enzyme. 
Thus, mutations in the CR3 sequence could influence the amount of CR3 that is 
phosphorylated and impair interactions with other factors required for function, and one 
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Figure 9 (previous page):  Phosphorylation of Par-3 and other substrates by atypical 
Protein Kinase C and competition between its substrates. 
(A) The human Par-3 CR3 peptide is phosphorylated by the human aPKC kinase domain. 
Radioactive signal from phosphorimaging (32P) from the Par-3 CR3 peptide (provided by Soriano 
et al.) is shown after incubation with 32P-ATP and aPKC and tris-tricine gel electrophoresis. The 
signal from a reaction using a “Dead” version of the kinase harboring an inactivating D388A 
mutation is included to show the level of background phosphorylation signal. 
(B) Maltose Binding Protein (MBP) fusions of aPKC Phosphorylation Motifs (APMs) from 
several substrates, including Par-3, are phosphorylated by the aPKC kinase domain. 
Radioactive signal from the designated proteins are shown after incubation with 32P-ATP and 
aPKC and polyacrylamide gel electrophoresis. The signal from reactions containing MBP and 
MBP fusion of Par-3 CR3 with its phosphorylated residue mutated to alanine (S827A) are 
included to show the level of background phosphorylation signal. The radioactivity signal from 
phosphorimaging (32P) and total protein with Coomassie Brilliant Blue (CBB) are shown. 
(C) Kinetic parameters of aPKC substrates determined by measuring the dependence of 
reaction rates on substrate concentration. The kinetic parameters kcat and KM were determined 
for each substrate from the substrate concentration dependence of the initial rate. The catalytic 
efficiency (kcat/KM), a standard measure of substrate quality, is also shown. Errors represent 
standard error from three experimental trials. The kinase domain from the species corresponding 
to the appropriate substrate was used for each experiment. aPKC Phosphorylation Motif (APM). 
CR3 is the APM for Par-3. 
(D) Substrate competition experimental scheme. A “model substrate” (S1) is held at a constant 
concentration while the concentration of a test substrate (S2) is varied. At low concentrations of 
S2, phosphorylation of S1 predominates. At intermediate concentrations, both substrates are 
phosphorylated. At high concentrations, phosphorylation of S1 predominates. 
(E) Monitoring substrate competition with ADP concentration can lead to false negatives. 
Using kinetic modeling we identified parameters in which monitoring ADP would not be 
sensitive to competition. This deficiency arises because the ADP assay cannot distinguish 
between phosphorylation of the two protein substrates, S1 and S2 (phosphorylation of either 
substrate produces ADP). As the enzyme transitions from the model protein substrate to the 
“inhibitor” substrate (e.g. as the concentration of competitive substrate is increased), ADP 
continues to be produced and detected by the assay. If the kinetic properties of the substrates were 
such that ADP was produced in the same amount, no change in signal would be observed even if 
the competitive substrate very effectively inhibited phosphorylation of the model substrate (i.e. a 
false negative), as is the case in this example where S1 and S2 are phosphorylated at roughly the 
same rate. Although S2 completely inhibits phosphorylation of S1 at high concentrations of S2, 
this effect does not influence the amount of ADP produced. 
(F) Detection of substrate competition using the radioactive protein product assay. Because the 
ADP concentration assay is prone to false negatives when detecting substrate competition, we 
performed the competition experiment using the radioactive protein product assay with a panel of 
aPKC substrates. This assay directly detects protein product and can therefore be used to 
specifically monitor the extent of model substrate phosphorylation. We used this assay to measure 
inhibition of “model substrate” (GST-PSS) phosphorylation by the Par-3 CR3 and a number of 
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other known aPKC substrates. Phosphorylation of the model substrate is shown after 
polyacrylamide gel electrophoresis and phosphorimaging as a function of the concentrations of 
MBP fusions of Par-3, Par-1, Numb APMs.   
(G) All aPKC substrates inhibit phosphorylation of the model substrate.  The IC50 values for 
inhibition of model substrate phosphorylation by Par-3, Par-1, Lgl, Kibra, and Numb APMs are 
shown. We observed inhibition of model substrate phosphorylation with all tested aPKC 
substrates, including Par-1 and Numb. Error bars represent standard error from the plotted 
experimental trials. 
(H) The Par-1 APM inhibits phosphorylation of the Par-3 CR3.  The amount of Par-3 CR3 
phosphorylation by aPKC is shown as a function of Par-1 APM concentration. Analysis of the 
phosphorimager intensities (graph below) yields an IC50 of 23 µM. Error bars represent standard 
error from two experimental trials. 
(I) Table of constructs used in this study.   
 
or both of these effects could lead to polarity phenotypes. We tested one such CR3 
mutation (“AAT”) used by Soriano et al. and found that it significantly reduces its quality 
as an aPKC substrate (Figure 9C). In fact, Soriano et al. found that another Par-3 CR3 
mutation (“AXA”) leads to a significant reduction in phosphorylation in cells (see their 
Figure 5F). We conclude that the polarity phenotypes observed by Soriano et al. could 
arise simply from the fact that less phosphorylated Par-3 is produced in the CR3 mutant 
context. More broadly, these results emphasize the difficulty of isolating potential 
substrate competition as an experimental variable. 
Finally, we note that current in vivo observations do not strongly support a role 
for Par-3 in inhibiting aPKC’s catalytic activity. For example, when Par-3 and aPKC are 
colocalized, aPKC is active as assessed by its ability to clear other substrates from the 
cortex (Atwood et al., 2007; Morais-de-Sá et al., 2010). In no context that we are aware 
of does loss of Par-3 lead to increased aPKC catalytic activity, as would be expected for 
an inhibitor of catalytic activity. Even for substrates such as Lgl that are known to 
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antagonize aPKC, this function is most clearly related to an effect on aPKC’s 
localization, not its catalytic activity (Grifoni et al., 2007; Lee et al., 2006).  
In conclusion, we have found that human Par-3 CR3 is phosphorylated by the 
aPKC kinase domain, as is the case for the fly, worm, and mouse orthologues. We also 
found that all substrates can inhibit aPKC’s ability to phosphorylate another substrate, 
consistent with the general principle that substrates compete with one another for access 
to the active site. While these results do not preclude the possibility that activating steps 
are involved in Par-3 CR3 phosphorylation by the aPKC kinase domain, or that CR3 
inhibition of aPKC is functionally relevant, they do call into question the key 
observations that motivate both potential activities and the separation of aPKC substrates 
into “substrate” and “inhibitor substrate” categories. Further in vitro studies with the fully 
reconstituted Par complex, and in vivo analyses of aPKC activity will be required for a 
complete understanding of Par-3’s role in regulating aPKC-mediated polarity. 
 
METHODS 
Expression and Purification of aPKC kinase domain.  
The pCMV plasmid containing the aPKC coding sequence and NH2-terminal His6 
affinity tag were transfected into HEK293-F suspension cells using 293fectin (Thermo 
Fisher) and grown in shaker flasks for 24h at 37°C. Cells were collected by 
centrifugation, resuspended in nickel lysis buffer (50 mM NH3PO4, 300 mM NaCl, 10 
mM Imidazole, pH 8.0), and lysed by probe sonication. After clearing cellular debris by 
centrifugation, aPKC protein was precipitated by gentle mixing with ammonium sulfate 
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to a final concentration of 45% (w/v) for 30 minutes and then collected by centrifugation. 
Precipitated protein was resuspended in nickel lysis buffer and gently mixed with Ni2+-
nitrilotriacetic acid resin for 45 minutes. Resin was washed 2x with nickel lysis buffer 
supplemented with 5 mM MgCl2 and 100 µM ATP followed by a final wash with nickel 
lysis buffer. Protein was eluted with nickel elution buffer (50 mM NH3PO4, 300 mM 
NaCl, 300 mM Imidazole, pH 8.0) and buffer exchanged for 20mM Tris, pH 7.5, 100 
mM NaCl, 1mM DTT, 5 mM MgCl2, and 100 µM ATP using a PD10 desalting column. 
Finally, protein was purified by Source Q anion exchange chromatography with a salt 
gradient from 100 mM to 550 mM.  Fractions from the elution peak containing aPKC 
phosphorylated at the activation loop and turn motif, as verified by reactivity with 
phosphospecific antibodies (Santa Cruz Biotech), were pooled and buffer shifted to 20 
mM HEPES, pH 7.5, 100 mM NaCl, 5 mM MgCl2, 100 µM ATP, and 1 mM DTT, 
followed by flash freezing and storage at -80°C until use. Kinase domains were 
quantified by western blot analysis using a standard curve generated with a sample of 
known concentration using an anti-aPKC antibody (Santa Cruz Biotech).   
 
Expression and Purification of Substrates. 
Substrate sequences were cloned into either pMAL or pGEX bacterial expression 
vectors allowing substrates to be tagged with either NH2-terminal MBP or GST affinity 
tags, respectively. Proteins were expressed in transformed E. coli BL21(DE3) followed 
by purification on amylose (MBP) or glutathione (GST) affinity resins using standard 
methods. Proteins were buffer shifted over PD10 columns (GE Healthcare) to 20 mM 
HEPES, 100 mM NaCl, 1 mM DTT, pH 7.5 followed by flash freezing and storage at -
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80°C. Bacterially expressed substrates were quantified by comparing Coomassie Brilliant 
Blue staining to that of a standard curve generated using known concentrations of Bovine 
Serum Albumin. Enzyme kinetics assays. Assays were conducted in 18.1 mM HEPES, 90 
mM NaCl, 4.6 mM MgCl2, 0.1 mM ATP (1 µCi 𝛾-32P), and 0.0045% Tween at 21° C, pH 
7.5.  The kinase, at a final concentration of 100 nM for single point assays and between 
0.125 nM and 1 nM for substrate concentration dependence assays (i.e. Michaelis Menten 
kinetics), was incubated for 20 minutes followed by addition of substrate (1 µM for 
single point assays and between 0 and 50 µM for substrate concentration dependence 
assays) to initiate the reaction. Single point assay samples were quenched after 30 
minutes with SDS loading dye and subjected to polyacrylamide gel electrophoresis to 
separate substrates from unreacted ATP, followed by final analysis by phosphorimaging. 
For substrate concentration dependence samples, the reaction was ended after 10 minutes 
by addition of quench buffer to a final concentration of 68 mM H3PO4, 0.91 M NaCl, and 
0.91 mM DTT and applied to a nitrocellulose membrane via a Minifold-1 slot blotter 
(Whatman) to separate product from unreacted ATP followed by phosphorimaging 
quantification. Intensities obtained by phosphorimaging were converted to product 
concentrations using a standard curve generated concomitantly using a phosphorylated 
standard. Initial rates were determined by linear fits to the time dependence of product 
formation using Prism 8 (GraphPad). The kcat and KM kinetic parameters were determined 
by fitting the dependence of initial rate on substrate concentration using Prism 8 which 
directly yielded KM and Vmax, and kcat was determined by dividing Vmax by the 
concentration of aPKC.  Error was assessed by averaging the velocities of at least 3 
independent experiments and taking the standard error.  
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Competition assays.  
For competition assays, the pseudosubstrate from PKC epsilon was used as the 
model substrate with an alanine to serine mutation (“PSS”) containing an NH2-terminal 
GST affinity tag (or Par-3 CR3 in the case of the Par-1 inhibition of Par-3 experiment 
shown in Figure S1H).  Assays were conducted in 18.1 mM HEPES, 90 mM NaCl, 4.6 
mM MgCl2, 0.1 mM ATP (1 µCi 𝛾-32P), and 0.0045% Tween at 21 °C, pH 7.5.  The 
kinase, at a final concentration of 0.25 nM was incubated for 20 minutes followed by the 
addition of substrates (20 µM GST-PSS and MBP-substrates titrated from 100 µM–1 
nM). Reactions were quenched after 10 minutes with SDS loading dye and subjected to 
polyacrylamide gel electrophoresis to separate substrates from unreacted ATP, followed 
by final analysis by phosphorimaging. Band intensities were analyzed using ImageJ. IC50 
values were analyzed using Prism (GraphPad) by fitting with the inhibitor vs normalized 
response function. Error was assessed by averaging two independent experiments and 
determining the standard error.  
 
Kinetic Simulations.  
COPASI kinetic simulation software was used to simulate kinetic parameters that 
could lead to false negatives while using ADP detection technologies to analyze 
competitive inhibition between two competing substrates. For the simulations in Figure 
S1E, substrate 1 (S1) had a KM of 105 µM and a kcat of 0.44 s-1 and was held at a constant 
concentration of 8 µM. Substrate 2 (S2) had a KM and kcat of 7 µM and 0.09 s-1 
respectively while the concentration was varied from 1.0 nM – 1.0 mM. The enzyme and 
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ATP concentrations were set to 1 nM and 100 µM respectively.  The concentrations of 
ADP, phosphorylated substrates (S1-P and S2-P) were evaluated after 10 minute 
simulation time, while varying the concentration of S2. 
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Bridge to Chapter III 
 In this chapter I have argued that the interaction between the Par-3 APM and the 
aPKC kinase domain does not support a mechanism for apical recruitment of the Par-
complex by Par-3.  The interaction between the Par-3 APM and the kinase domain of 
aPKC is, like all enzyme/substrate interactions, transient.  While the turnover of Par-3 is 
lower than other substrates, the catalytic efficiency is comparable with other known 
aPKC substrates.  Furthermore, I show that while Par-3 does indeed inhibit aPKC 
catalytic activity, it does so comparable to other aPKC substrates and in fact all substrates 
can inhibit catalytic activity depending on the relative concentrations.  In Chapter III I 
assess the role of all other reported interactions between Par-3 and purified reconstituted 
Par-complex.  Surprisingly, I found that none of the previously reported interactions are 
required for complex assembly.  However, we do identify a novel interaction that is 
 
 
 
34 
required for aPKC’s apical polarization.  This work is important to our understanding of 
the role Par-3 plays in polarizing the Par-complex. 
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CHAPTER III 
A CONSERVED aPKC PDZ BINDING MOTIF INTERACTS WITH PAR-3 AND 
MEDIATES CORTICAL POLARITY. 
 
*This chapter contains previously published co-authored material 
 
Holly, R.W., Jones, K., Prehoda, K.E. (2020) A Conserved aPKC PDZ Binding Motif 
That Interacts With Par-3 and Mediates Cortical Polarity.  Current Biology.  30 (5), 893-
898. 
 
Author contributions:  R.H performed all in vitro experiments.  K.J performed the in vivo 
experiments. K.E.P and R.H were both involved in the experimental design.  K.E.P and 
R.H wrote the manuscript.  K.E.P directed the research. 
 
SUMMARY 
Par-3 regulates animal cell polarity by targeting the Par complex proteins Par-6 
and atypical Protein Kinase C (aPKC) to specific cortical sites. Although numerous 
physical interactions between Par-3 and the Par complex have been identified (Izumi et 
al., 1998; Joberty et al., 2000; Lin et al., 2000; Renschler et al., 2018; Soriano et al., 
2016; Wodarz et al., 2000), we discovered a novel interaction between Par-3’s second 
PDZ domain and a highly conserved aPKC PDZ binding motif (PBM) that is required in 
the context of the full-length, purified Par-6/aPKC complex. We also found that Par-3 is 
phosphorylated by the full Par complex and phosphorylation induces dissociation of the 
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Par-3 phosphorylation site from aPKC’s kinase domain but does not disrupt the Par-3 
PDZ2 – aPKC PBM interaction. In asymmetrically dividing Drosophila neuroblasts, the 
aPKC PBM is required for cortical targeting, consistent with its role in mediating a 
persistent interaction with Par-3. Our results define a physical connection that targets the 
Par complex to polarized sites on the cell membrane. 
 
RESULTS AND DISCUSSION 
Par complex phosphorylation of Par-3 
The catalytic activity of aPKC defines mutually exclusive cortical domains in 
diverse animal cells (Lang and Munro, 2017; Venkei and Yamashita, 2018). Par-6 and 
aPKC are recruited to specific cellular sites where aPKC phosphorylation polarizes 
downstream factors by displacing them from the Par cortical domain. For example, in 
Drosophila neural stem cells or neuroblasts, the Par complex localizes to an apical 
cortical domain during mitosis where it excludes neuronal differentiation factors (Atwood 
and Prehoda, 2009; Rolls et al., 2003; Wodarz et al., 1999). Apical exclusion separates 
these factors into a distinct cortical domain at the basal cortex, which is segregated into 
the basal daughter cell following cytokinesis (Knoblich, 2010; Venkei and Yamashita, 
2018). Par polarized factors such as Miranda and Numb contain sequences that bind the 
membrane but are also phosphorylation motifs for aPKC (Bailey and Prehoda, 2015). The 
direct connection of aPKC’s catalytic activity to the polarization of downstream factors 
makes the regulatory pathways that control its cortical targeting critical to animal cell 
polarity. 
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In many cellular contexts, Par-3 (Bazooka in flies) is essential for recruitment of 
Par-6 and aPKC to specific cortical sites (Lang and Munro, 2017; Venkei and Yamashita, 
2018; Wen and Zhang, 2018). Par-3’s role in regulating Par complex cortical recruitment 
is thought to be direct because five physical interactions have been discovered with both 
Par-6 and aPKC (Izumi et al., 1998; Joberty et al., 2000; Lin et al., 2000; Renschler et al., 
2018; Soriano et al., 2016; Wodarz et al., 2000) (Figure 10A). Four of the interactions 
involve at least one of Par-3’s three PDZ protein interaction domains: Par-3 PDZ1 
binding to the Par-6 PDZ domain (Joberty et al., 2000; Li et al., 2010b; Lin et al., 2000), 
 
 
 
 
Figure 10 Par-6/aPKC binds and phosphorylates Par-3.  (A) Domain structure (not to 
scale) and previously described Par-3 interactions with the Par complex. Single direction 
arrows define the five previously identified Par-3 interactions with Par-6/aPKC. PBM, PDZ 
Binding Motif; APM, aPKC Phosphorylation Motif (aka CR3); PS, pseudosubstrate. Double 
headed arrow denotes the interaction between Par-6 and aPKC.  (B) Par-3 interaction with and 
phosphorylation by the Par complex. Solid phase (amylose resin) bound Maltose Binding 
Protein (MBP) fused Par-3 (MBP-Par-3 has an expected mass of 199.9 kDa) with the Par-
6/aPKC complex. CBB, Coomassie Brilliant Blue; α-pS980-Par-3, antibody specific to the 
S980 site within the APM [17]. Shaded region indicates fraction applied to gel (soluble phase 
or solid phase components after mixing with soluble phase components and washing).  
 
A B
Par-3
(Baz)
PB1 C1 Protein Kinase
PS
aPKC
PB1
semi-
CRIB
PDZPar-6
Pa
r c
om
pl
ex
PBM
APM
OD PDZ1 PDZ2 PDZ3
?
MBP
MBP-Par-3
Par-6/
aPKC
So
lid
ph
as
e
So
lu
bl
e
ph
as
e
њ-
aP
KC
њ-
Pa
r-6
WT S980A
њ-
pS
98
0-
Pa
r-3
190
MW (kDa)
115
C
BB
190
115
70
Par-6
aPKC
50
 
 
 
38 
Par-3 PDZ1 and PDZ3 domain interactions with Par-6’s PDZ Binding Motif (PBM) 
(Renschler et al., 2018), and an interaction with an undefined region of aPKC that 
requires both Par-3 PDZ2 and PDZ3 (Wodarz et al., 2000). Additionally, because Par-3 is 
an aPKC substrate, the aPKC kinase domain interacts with Par-3’s aPKC 
Phosphorylation Motif (APM aka CR3). Although protein kinases are typically thought to 
interact transiently with their substrates, the interaction with the APM has been proposed 
to mediate complex assembly (Izumi et al., 1998; Nagai-Tamai et al., 2002; Soriano et 
al., 2016). Previous investigations used small fragments of the Par complex that did not 
contain all potential binding motifs, such that it was not possible to assess whether any of 
the interactions are required for binding in the context of the purified, full-length Par-
6/aPKC complex. Furthermore, none of the interactions have been shown to be required 
for cortical targeting of aPKC in a functional context. 
We investigated Par-3 interactions with the Par-6/aPKC complex by 
reconstituting full-length Drosophila Par-6 and aPKC. While we were able to purify the 
Par-6/aPKC complex to a high degree (Figure 10B), Par-3 is very large (157.4 kDa) and 
the Maltose Binding Protein fused Par-3 (MBP-Par-3; total mass 199.9 kDa) we were 
able to obtain included significant amounts of degradation products in addition to full-
length protein. Nevertheless, using this preparation we were able to detect an interaction 
with reconstituted Par complex using a qualitative affinity chromatography (i.e. “pull-
down”) assay (Figure 10B). Additionally, we detected phosphate transfer to full-length 
Par-3 (and some smaller fragments with masses consistent with COOH-terminal 
truncations that contain the APM) using an antibody specific to the phosphorylated APM 
(Morais-de-Sá et al., 2010) (Figure 10B). Phosphorylation of Par-3 by aPKC has been 
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controversial (Holly and Prehoda, 2019; Soriano et al., 2016; Thompson and McDonald, 
2019). This result contributes to our understanding of the process by demonstrating that 
aPKC phosphorylates Par-3 in the context of the full-length, purified Par complex in 
addition to the isolated catalytic domain and APM peptide (Holly and Prehoda, 2019).  
 
Par-3 PDZ2 is required for interaction with the Par complex 
Using the system of purified Par complex and MBP-fusions of full-length Par-3 
and its degradation products, we attempted to identify Par-3 domains required for 
interaction with the full Par complex (Figure 11). We also tested the Par-6 PBM within 
the Par complex as it has been reported to bind both the Par-3 PDZ1 and PDZ3 domains 
 
 
 
Figure 11: Par-3 PDZ2 is required for Par complex binding.  (A) Effect of removing Par-3 
domains on its interaction with the Par complex. Solid phase (amylose resin) bound Maltose 
Binding Protein (MBP) fused Par-3 (full length or the PDZ1-APM fragment) was incubated with 
soluble Par-6/aPKC complex. CBB, Coomassie Brilliant Blue. Shaded region indicates fraction 
applied to gel (soluble phase or solid phase components after mixing with soluble phase 
components and washing).  (B) Effect of removing the Par-6 PDZ Binding Motif on the Par 
complex interaction with Par-3. Labeling as in A. 
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(Renschler et al., 2018) (Figure 11B). We included ATP in binding experiments since 
Par-3 is a substrate in the context of the full Par complex (Figure 11B). Using this 
experimental setup, we identified Par-3 PDZ2 as a required interaction domain for 
binding to the full Par complex (Figure 11).  
 
A conserved aPKC PDZ Binding Motif is required for interaction with Par-3 
To determine the mechanism by which Par-3 PDZ2 mediates binding to the Par 
complex, we first sought to identify the recognition site on the complex. The Drosophila 
aPKC COOH-terminal sequence has the characteristics of a “class 3” PDZ Binding Motif 
(PBM) (Figure 12A) and is consistent with the binding specificity of the PDZ2 domain as 
assessed using a phage display assay (Yu et al., 2014). The aPKC COOH-terminal 
sequence is also highly conserved among metazoan orthologues (Figure 12A), the same 
evolutionary interval in which Par-3 is found (Fahey and Degnan, 2010). We tested 
whether the aPKC COOH-terminus is required for  the interaction with Par-3 by 
purifying Par complex lacking aPKC’s final six residues. As shown in Figure 12B, the 
aPKC COOH-terminus is required for Par-3’s interaction with the Par complex.  
To test whether the Par-3 PDZ2 and aPKC COOH-terminus are sufficient for 
binding, we examined the interaction of the isolated motifs. As shown in Figure 12C, the 
isolated proteins are sufficient for complex assembly. In general, PDZ–PBM interactions 
are strongly dependent on the identity of the terminal residue and we found that Par-3 
PDZ2 failed to bind the aPKC COOH-terminus when the final residue was mutated from 
valine to alanine (aPKC V606A; Figure 12C). We conclude that the aPKC COOH- 
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Figure 12: A conserved aPKC PDZ Binding Motif required for Par-3’s interaction with 
the Par complex.  (A) Sequence alignment of the aPKC and Par-6 COOH-terminuses from 
diverse metazoan organisms.  (B) Effect of removing the aPKC PDZ Binding Motif on the Par 
complex interaction with Par-3. Solid phase (amylose resin) bound Maltose Binding Protein 
(MBP) fused Par-3 (full length or the PDZ1-APM fragment that contains all known 
interaction domains) was incubated with wild type Par-6/aPKC or the complex lacking 
aPKC’s PBM (Par-6/aPKC∆PBM). Arrowheads indicate Par-6 and aPKC. CBB, Coomassie 
Brilliant Blue. Shaded region indicates fraction applied to gel (soluble phase or solid phase 
components after mixing with soluble phase components and washing).  (C) Interaction of 
Par-3 PDZ2 with the aPKC PBM. Labeling as in B. For other organisms, see Figure S1A.  (D) 
Comparison of Par-6/aPKC and Par-6/aPKC∆PBM binding to Par-3 PDZ1-APM using an 
equilibrium supernatant depletion assay [22]. Mean values of the fraction of the Par complex 
bound, as determined by both anti-Par-6 and anti-aPKC western blot analysis (see Figure 
S1B), from two experimental replicates are shown along with standard error at each 
concentration.  (E) Schematic depicting how the lack of ATP may convert a transient 
interaction between the Par-3 APM and the aPKC kinase domain into a persistent one.  (F) 
Effect of nucleotide on the interaction of Par-3 with Par-6/aPKC∆PBM. Solid phase (amylose 
resin) bound Maltose Binding Protein (MBP) fused Par-3 (full length and with the specified 
interaction domains removed) was incubated with Par-6/aPKC lacking aPKC’s PBM (Par-
6/aPKC∆PBM). “ADP” or “ATP” indicates which nucleotide was present in the binding 
reaction. CBB, Coomassie Brilliant Blue. Shaded region indicates fraction applied to gel 
(soluble phase or solid phase components after mixing with soluble phase components and 
washing).  
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terminus is a bona fide PDZ Binding Motif (PBM). We also confirmed that the aPKC 
PBM and Par-3 PDZ2 interaction is broadly conserved  across metazoans by examining 
orthologues from a chordate (human), a placozoan (Trichoplax), and a cnidarian (Hydra), 
in addition to the arthropod Drosophila (Figure S1A). We observed binding for each of 
the orthologous pairs indicating that the interaction is conserved across diverse metazoan 
organisms. Together, these results indicate that the Par-3 PDZ2 and aPKC PBM are 
sufficient for binding and their interaction is conserved across metazoa. 
To assess the role of the Par-3 PDZ2–aPKC PBM interaction quantitatively, we 
implemented an equilibrium supernatant depletion assay (Pollard, 2010). We measured 
the affinity of the Par-3 PDZ1-APM for the Par complex, as this region could be purified 
to a level suitable for quantitative measurements (Figure 12B). Addition of Par-3 PDZ1-
APM depleted Par-6 and aPKC from the supernatant consistent with a Kd of 0.7 µM 
(95% confidence interval of 0.5 – 0.9 µM; Figures 12D, S2B). To determine the effect of 
disrupting the Par-3 PDZ2–aPKC PBM interaction on binding affinity, we examined Par-
3 PDZ1-APM binding to Par-6/aPKC∆PBM. We did not observe sufficient depletion of 
Par-6 and aPKC∆PBM by PDZ1-APM to allow fitting to a binding isotherm (Figures 
12D, S2B), indicating the absence of the aPKC PBM substantially decreases the affinity 
of the Par-3 interaction with the Par complex, consistent with the results of qualitative 
measurements (Figure 12B). 
 
The role of Par-3 phosphorylation in its interaction with the Par complex  
Our results indicate that the Par-3 PDZ2 and aPKC PBM are required for Par-3’s 
interaction with the Par complex (Figures 11A, 12B). The requirement for these domains 
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suggests that the Par-3 phosphorylation site (i.e. APM) does not form a persistent 
interaction with the Par complex. However, this conclusion appears to be in conflict with 
previous work showing that the Par-3 APM is sufficient for binding to the aPKC kinase 
domain, both with binding assays and structure determination using x-ray crystallography 
(Soriano et al., 2016; Wang et al., 2012). Furthermore, a stable APM-kinase interaction 
forms the basis of a model in which the unphosphorylated Par-3 APM forms a stable, 
persistent interaction with the aPKC kinase domain that is not phosphorylated until an 
unknown activating event occurs (Soriano et al., 2016). The finding that Par-3 is 
phosphorylated by the full Par complex (Figure 10B) is inconsistent with this model, but 
it does not fully resolve whether the Par-3 APM is sufficient for forming a stable, 
persistent interaction with the Par complex  (Soriano et al., 2016; Wang et al., 2012).  
We hypothesized that the presence of ATP could influence the binding behavior 
of the Par-3 APM with the Par complex. A key difference between our experiments and 
previous reports is that our experiments included ATP, whereas previous binding 
experiments and structural analysis lacked ATP (Soriano et al., 2016; Wang et al., 2012). 
Without ATP, completion of the protein kinase catalytic cycle is not possible, and 
interactions that would otherwise form transiently could persist (Figure 12E).  
We tested whether the Par-3 APM forms a stable, persistent interaction with the 
Par complex in the absence of ATP. We were able to detect binding between Par-3 and 
the Par complex after replacing ATP with ADP in a context where the Par-3 PDZ2 – 
aPKC PBM interaction is disrupted (Figure 12F). This interaction requires the APM, 
leading us to conclude that the Par-3 APM can form a persistent interaction with the Par 
complex, but only in the absence of ATP. When ATP is present the APM interacts 
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transiently with the Par complex, because it is phosphorylated (Figure 10B) and 
subsequently dissociates (Figures 12B,D,F). Under the same conditions, the Par-3 PDZ2 
interaction with the Par complex is not disrupted, however (e.g. Figure 12B,D). Although 
it is possible to form a stalled complex between the Par-3 APM and the Par complex in 
the absence of ATP, we propose that persistent binding of the APM to the kinase domain 
due to the lack of ATP is unlikely in vivo because ATP concentrations are high under 
normal cellular conditions. 
 
The aPKC PDZ Binding Motif is required for neuroblast polarization 
Although numerous interactions have been identified between Par-3 and Par-
6/aPKC (Izumi et al., 1998; Joberty et al., 2000; Lin et al., 2000; Renschler et al., 2018; 
Soriano et al., 2016; Wodarz et al., 2000), none have been demonstrated to be required 
for cortical targeting of the Par complex. In fact, the interactions of Par-6 with Par-3 have 
been shown to be dispensable for function (Li et al., 2010, 2010; Renschler et al., 2018). 
To determine if the Par-3 PDZ2 – aPKC PBM interaction is required for Par complex 
polarization, we investigated the localization of aPKC harboring the V606A PBM point 
mutation during neuroblast asymmetric division by expressing aPKC-V606A in larval 
brain neuroblasts and comparing its localization to that of wild-type aPKC. Consistent 
with previous observations (Oon and Prehoda, 2019; Rolls et al., 2003), we found that 
wild-type aPKC is polarized to a cortical crescent around the apical pole at metaphase 
(Figures 13A, B). In contrast, aPKC-V606A remained in the cytoplasm and was not 
recruited to the cortex, even though the localization of Par-3 was unaffected (Figures 
13A-D). The aPKC-V606A protein also failed to be recruited to the apical cortex in 
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neuroblasts lacking endogenous aPKC (Figure S2). We conclude that the Par-3 PDZ2-
 
 
Figure 13: aPKC polarization requires its PDZ Binding Motif.  
(A) Protein localization in metaphase neuroblasts expressing WT or V606A aPKC. The 
localization of HA-tagged WT or V606A aPKC, expressed using Worniu-GAL4/UAS, is 
shown with the basal marker Miranda, total aPKC (transgenically expressed and endogenous) 
using an anti-aPKC antibody, and DNA (DAPI). Scale bar is 5 µm. A similar analysis in aPKC 
mutant neuroblasts is shown in Figure S2.  (B) Gardner-Altman estimation plot of effect of the 
aPKC V606A mutation on aPKC cortical localization. Ratios of apical cortical to cytoplasmic 
anti-HA signal intensities are shown for individual metaphase neuroblasts expressing either 
HA-WT or HA-V606A aPKC. Statistics: Bootstrap 95% confidence interval (bar in “V606A 
minus WT” column).  (C) Localization of Par-3 in metaphase neuroblasts expressing WT or 
V606A aPKC, as in panel d.  (D) Gardner-Altman estimation plot of effect of the aPKC 
V606A mutation on Par-3 cortical localization. Apical cortical to cytoplasmic signal intensities 
of anti-Par-3 signals are shown for individual metaphase neuroblasts expressing either HA-WT 
or HA-V606A aPKC. Statistics: Statistics: Bootstrap 95% confidence interval (bar in “V606A 
minus WT” column).  (E) Par-3 interactions with Par-6/aPKC analyzed in this study. The Par-3 
PDZ2–aPKC PBM interaction forms a persistent connection while the aPKC kinase domain 
interacts transiently with the Par-3 APM when ATP is present. 
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aPKC PBM interaction is required for cortical recruitment and polarization of aPKC in 
neuroblasts. 
We have examined the interaction of Par-3 with the full-length Par complex and 
found that Par-3 PDZ2 and a previously unrecognized PBM at the COOH-terminus of 
aPKC are required for complex assembly (Figure 13E). The Par-3 phosphorylation site 
(APM) can also form a persistent interaction with the aPKC kinase domain, but only if 
phosphorylation is not allowed to occur due to the absence of ATP. Unlike the APM–
kinase domain interaction, the Par-3 PDZ2  interaction with the aPKC PBM is not 
influenced by the presence of ATP, suggesting that additional mechanisms besides APM 
phosphorylation must exist to dissociate Par-3 from the Par complex, an important 
component of current polarity models (Morais-de-Sá et al., 2010; Rodriguez et al., 2017; 
Wang et al., 2017). 
The identification of Par-3 PDZ2 domain as a key factor in recruiting the Par 
complex to the cortex during animal cell polarization is consistent with previous work 
demonstrating that while Par-3 PDZ1 and 3 are dispensable in C. elegans, PDZ2 is 
required for cortical recruitment of Par-6 and aPKC (Li et al., 2010). It is also consistent 
with work in both C. elegans and Drosophila showing that the interaction of Par-6 with 
Par-3 is not required (Li et al., 2010; Renschler et al., 2018). In Drosophila, the role of 
PDZ2 is less clear but is known to be required for downstream effects on epithelial 
structure (McKinley et al., 2012). We suggest that the Par-3 PDZ2 – aPKC PBM 
interaction represents an important physical connection for animal cell polarity and that 
the reconstitution approach used to identify this interaction will likely be useful for 
understanding how other regulatory molecules, such as Cdc42, control polarity. 
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STAR METHODS 
Lead contact and materials availability 
All request for reagents should be directed to Lead Contact, Ken Prehoda. 
(prehoda@uoregon.edu) 
 
Experimental model and subject details 
Animals: Drosophila 
A mix of male and female larvae were used for all in vivo experiments. The 
strains used in this study were: ;Worniu-Gal4 (BDSC_56553), ; FRT-G13, 
aPKCK06403/CyO (Gift from C.Q. Doe), and elav-Gal4, UAS-mCD8:GFP, hs:flp; FRT-
G13, tubPGal80 (BDSC_5145). 
In addition, two fly lines were created for this study, 3xHA-aPKC 1-606 and 
3xHA-aPKC V606A. These were made using Phi-C31 integration. In brief, the coding 
region of aPKC wild-type (1-606) (A1Z9X0) or aPKC PBM mutant (V606A) were 
cloned into a pUAST vector (GenBank: EF362409.1) modified to contain an N-terminal 
3xHA tag. Vector was injected into attP2 containing flies in a y, w background 
(BDSC_8622) and integrated using PhiC31 (BestGene, Inc.). F1 generation progeny were 
backcrossesd to y, w adults and F2 progeny were screened for the presence of red eyes. 
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Method details 
Expression and Purification of Par-complex 
Plasmids (pCMV) containing the coding sequences for aPKC and His-Par-6 
including the mutants aPKC∆PBM or His-Par-6∆PBM were co-transfected into 
HEK293-F suspension cells using 293fectin (Thermo Fisher) and grown in shaker flasks 
for 60h at 37°C. Cells were collected by centrifugation at 1000 RPM x 3 minutes, 
resuspended in lysis buffer (50 mM NH3PO4, 300 mM NaCl, 10 mM Imidazole, pH 8.0), 
and lysed by probe sonication at 50% amplitude, 0.3s/0.7s pulse on/off, 3 x 1 minute. 
After clearing cellular debris by centrifugation at 15k RPM x 20 minutes, protein was 
gently mixed with 4mL HisPur Cobalt (ThermoFisher) resin for 45 minutes. Resin was 
washed twice with 20mL lysis buffer supplemented with 5 mM MgCl2 and 100 µM ATP 
followed by a final wash with 20mL nickel lysis buffer. Protein was eluted with elution 
buffer (50 mM NH3PO4, 300 mM NaCl, 300 mM Imidazole, pH 8.0) by gravity and 
buffer exchanged with 20 mM Tris, pH 7.5, 100 mM NaCl, 1 mM DTT, 5 mM MgCl2, 
and 100 µM ATP using a PD10 desalting column (GE Healthcare). Finally, protein was 
purified by Source Q anion exchange chromatography with a salt gradient from 100 mM 
to 550 mM.  Fractions from the elution peak containing aPKC phosphorylated at the 
activation loop and turn motif, as verified by reactivity with phosphospecific antibodies 
(Rabbit a-PKCζ p-410 Santa Cruz Biotech, sc-12894-R; Rabbit a-PKC p560 Abcam 
ab62372), were pooled concentrated to 2.5mL, and buffer shifted to 20 mM HEPES, pH 
7.5, 100 mM NaCl, 5 mM MgCl2, 100 µM ATP, and 1 mM DTT, followed by 
concentration to ~400 µL.  Protein was aliquoted, flash frozen, and stored at -80°C until 
use. Par-complex was quantified by western blot analysis using a standard curve 
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generated with a sample of known concentration using an anti-aPKC antibody (Mouse a-
PKCζ H-1 Santa Cruz Biotech sc-17781).   
Expression and Purification of Par-3.  
Par-3 PDZ1 – APM (aa 309 – 991) was cloned (Gibson Cloning) into the pMal 
expression vector allowing for an NH2-terminal MBP tag as well as a COOH-terminal 
His6 tag to allow for dual affinity purification. Full length Par-3 (aa 1 - 1464) and all full 
length Par-3 domain deletion mutants were cloned into the pMal expression vector 
allowing for an NH2-terminal MBP tag.  Plasmids were transformed into E. coli BL21 
(DE3) cells, plated on LB + AMP and allowed to grow for 18h at 37 C.  Single colonies 
were picked to inoculate 100 mL of LB + AMP starter culture and grown for ~4h.  Starter 
culture was used to inoculate 2L LB + AMP and cultures were grown to an OD600 of 0.8 
– 1, followed by a 3h induction with 500 µM IPTG.  Cell pellets were collected at 5000 
RPM x 20 minutes and resuspended in lysis buffer (50 mM NH3PO4, 300 mM NaCl, 10 
mM Imidazole, pH 8.0).  Cell extracts were thawed under running water and lysed by 
probe sonication at 70% amplitude, 0.3s/0.7s pulse on/off, 3 x 1 minute.  Cellular debris 
was cleared at 15,000 RPM x 20 minutes and supernatant was added to 5mL HisPur 
cobalt resin and incubated for 30 minutes at 4 C.  Resin was washed 3 times with lysis 
buffer followed by elution with nickel elution buffer (50 mM NH3PO4, 300 mM NaCl, 
300 mM Imidazole, pH 8.0).  Fractions containing protein were pooled and concentrated 
to 2.5mL.  Proteins were buffer shifted over PD10 desalting columns (GE Healthcare) to 
20 mM Tris, pH 7.5, 200 mM NaCl, 1 mM DTT followed by flash freezing and storage at 
-80°C.  Protein was quantified by Bradford and purity was assessed by SDS-Page.  All 
other Par-3 constructs were cloned into pMal, pGex, or pET expression vectors allowing 
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for a single NH2-terminal MBP, GST, or His tag.  Proteins were expressed in transformed 
BL21 (DE3) competent cells as above.  MBP-protein cell extracts were resuspended in 
MBP lysis buffer (20mM Tris, pH 7.5, 200mM NaCl, 1mM EDTA, 1mM DTT).  GST-
protein cell extracts were resuspended in GST lysis buffer (1x PBS, pH 7.4, 1mM DTT).  
His-protein cell extracts were resuspended in nickel lysis buffer (50 mM NH3PO4, 300 
mM NaCl, 10 mM Imidazole, pH 8.0).  Cells were lysed and cleared as above.  For 
proteins used as bait in pull down assays, cleared lysate was aliquoted, flash frozen, and 
stored at -80 C.  Purified proteins were prepared by incubating cleared lysates with 5mL 
of amylose, glutathione, or HisPur cobalt resin for 30 minutes at 4 C.  Resin was washed 
3x with either GST, MBP, or nickel lysis buffer.  Proteins were then eluted with MBP, 
GST, or Nickel lysis buffer supplemented with 10 mM maltose, 10mM glutathione, or 
300mM Imidizole, respectively.  Fractions containing protein were pooled and 
concentrated to 2.5mL with Vivaspin 20 centrifugal concentrators.  Proteins were buffer 
shifted to 20mM HEPES, pH 7.5, 100mM NaCl, 1mM DTT.  Finally, proteins were 
concentrated to 500 µL, aliquoted, flash frozen, and stored at -80 C.  
   
Affinity chromatography interaction assay 
Amylose or glutathione resin was loaded with bacterial lysate (or his purification 
elutions in the case of Par-3 PDZ1-APM or Par-3 PDZ1-PDZ3 as these proteins contain 
COOH-terminal his tags) containing MBP- or GST-fusion protein for 30 minutes at 4° C 
and then washed with wash buffer three times (20 mM HEPES, pH 7.5, 100 mM NaCl, 5 
mM MgCl2, 0.5% Tween 20, and 1 mM DTT). Par-complex was then added to a 
concentration of 0.5 µM and incubated for 10 minutes at room temperature.  In the case 
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where ATP is present, ATP was used at a final concentration of 200 µM in all buffers 
throughout the pull down experiment and binding reactions were carried out for 30 
minutes at room temperature.  Finally, beads were washed two times briefly to remove 
unbound Par-complex and beads were resuspended in loading dye.  Samples were 
analyzed by SDS-Page and stained by Coomassie as well as Western Blot using a-aPKC 
(Mouse a-PKCζ H-1 Santa Cruz Biotech sc-17781) and rat a-Par-6.   
 
Supernatant depletion interaction assay 
Amylose resin was loaded with bacterial lysate containing MBP – Par-3 PDZ1 – 
APM for 30 minutes at 4° C and then washed with wash buffer (20 mM HEPES, pH 7.5, 
100 mM NaCl, 5 mM MgCl2, 200 µM ATP, 0.5% Tween 20, and 1 mM DTT). 2-fold 
serial dilutions of beads were prepared from 20 µL to 0.625 µL in a total volume of 200 
µL.  Par-complex was added to a final concentration of 40 nM diluted in wash buffer.  
After incubation for 30 minutes, beads were collected by centrifugation and an aliquot of 
supernatant was diluted in loading dye for western blot analysis using a-aPKC (Mouse 
a-PKCζ H-1 Santa Cruz Biotech sc-17781) and rat a-Par-6.  The concentration of protein 
loaded on the beads was verified by SDS-Page using a standard curve generated with 
known concentrations of BSA.  
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Drosophila Neuroblast Immunofluorescence 
Flies were allowed to lay in vials for 24 hours at room temperature, after which 
the flies were removed, and the vial was moved to 30˚C. During wandering third instar 
larval stage (5-6 days later), larvae were dissected within 20 minutes into Schneider’s 
Insect Medium (Sigma, S0146). Brains were fixed using 4% PFA in PBS for 20 minutes 
followed by 3 washes in PBST (1xPBS + 0.3% Triton-X 100, Sigma-Aldrich). Note that 
during all fixing, blocking, and washing steps, brains were kept moving on a nutator. At 
this stage brains could be kept for up to 3 days nutating at 4˚C in PBST or washed an 
additional 20 minutes in PBST before blocking and staining. Brains were blocked for 30 
minutes in PBSBT (PBST + 1% BSA, Fisher Scientific). Incubation in primary 
antibodies occurred overnight at 4˚C. Primary antibodies: Rat a-Mira (1:500; Abcam, 
ab197788), Mouse a-PKCζ H-1(1:1,000; Santa Cruz Biotech sc-17781), Rabbit a-PKCζ 
C-20 (1:1,000; Santa Cruz Biotech sc-216), Rabbit a-HA C29F4(1:1,000; Cell Signaling 
Technologies, 3724), Mouse a-HA (1:500; Covance, MMS-101P), and Guinea Pig a-
Baz(1:2,000; gift from C.Doe). Brains were then washed quickly followed by 3x15 
minutes washes in PBSBT. Incubation in secondary antibodies occurred at room 
temperature protected from light for 2 hours followed by a quick wash and 3x15 minutes 
washes in PBST. Secondary antibodies used were from Jackson Immunoresearch 
Laboratories, Inc.: Dk a-Rt Cy3 (712-165-153; 1:500), Dk a-Rb 647 (711-605-152; 
1:500), Dk a-Ms 488 (715-545-151), Dk a-Gp 405 (706-475-148; 1:500). Brains were 
stored in SlowFade Diamond with DAPI (Invitrogen, S36964) for at least 24 hours before 
imaging. Brains were imaged using a Leica TCS SPE upright confocal microscope using 
an ACS APO 40x 1.15 NA Oil CS objective. 
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Drosophila Neuroblast MARCM Clones 
To generate Drosophila neuroblast MARCM clones, FRT-G13, aPKCK06403/CyO 
Virgin flies were crossed to ;;3xHA-aPKC V606A male flies. The resulting non-Cyo 
male progeny were crossed to elav-Gal4, UAS-mCD8:GFP, hs:flp; FRT-G13, tubPGal80 
Virgins and allowed to lay for 24 hours at room temperature. The vials were then allowed 
to stay at room temperature for an additional 24 hours at which time they were heat-
shocked @37˚C for 90 minutes. This was followed by a possible second 90 minute heat-
shock within 18 hours. Vials were raised at 18˚C or room temperature until wandering 
third instar stage when they were dissected and stained as described above with the 
following antibodies: Primary antibodies: Rat a-Mira (1:500; Abcam, ab197788), Rabbit 
a-HA C29F4(1:1,000; Cell Signaling Technologies, 3724) or Mouse a-HA (1:500; 
Covance, MMS-101P), and Chicken a-GFP (1:500; Abcam, ab13970). Secondary 
antibodies: Dk a-Rt Cy3 (712-165-153; 1:500), Dk a-Rb 647 (711-605-152; 1:500) or 
Dk a-Ms 647 (715-605-151; 1:500), and Dk a-Ck 488 (703-545-155). Brains were 
imaged using a Leica TCS SPE upright confocal microscope using an ACS APO 40x 
1.15 NA Oil CS objective or an Olympus Fluoview FV1000 upright confocal microscope 
using a PlanApo N 60x 1.42 NA Oil objective.  
 
Quantification and statistical analysis 
Quantification of equilibrium dissociation constants 
The equilibrium dissociation constant for Par-3 PDZ1-APM binding to Par-
6/aPKC was calculated by measuring both Par-6 and aPKC western signals from the 
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supernatant of solutions containing increasing concentrations of amylose resin-bound 
MBP-Par-3 PDZ1-APM and fitting to the following equation: 
fb = free + (bound – free)*[Par-3 PDZ1-APM]/([Par-3 PDZ1-APM] + Kd) 
“fb” was calculated from the experimentally measured Par-6 and aPKC western signals 
using the equation 1 – Wx/W0 where Wx is the western signal at Par-3 concentration x 
and W0 is the western signal in the absence of Par-3 
“free” and “bound” are the fraction of Par-6/aPKC bound when saturated and in the 
absence of Par-3, respectively. These parameters were allowed to float 
Kd is the equilibrium dissociation constant.  
Fitting and calculation of 95% confidence intervals were done using the LMFIT python 
package. 
 
Drosophila Neuroblast Quantification 
All images were analyzed using Fiji. For quantification of apical cortical to 
cytoplasmic signal intensity ratios, corresponding signals were measured from an 
intensity profile averaged from 10 pixels across the apical portion of the cell parallel with 
the polarity axis in a central optical section. The apical value was taken as the highest 
peak data point corresponding with the apical domain of the cell, the cytoplasmic value 
was an average of 20 data points that were a distance of 10 points away from the apical 
value. 
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Bridge to Chapter IV 
In this chapter I have discovered a novel molecular interaction between Par-3’s 
PDZ2 domain and a PDZ binding motif (PBM) at the COOH-terminus of aPKC.  Using 
purified full-length Par-complex and Par-3, I show that this interaction is both necessary 
and sufficient for the persistent association between Par-3 and the Par-complex (Figure 
13).  Additionally, this interaction is not regulated by phosphorylation of Par-3.  As such, 
this work has challenged the current models regarding the apical polarization of aPKC 
which is foundational to our understanding of animal cell polarity.  In the next chapter I 
will give a brief summary of my findings and address a number of important questions 
that my research has led to.  
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CHAPTER IV 
FUTURE CONSIDERATIONS AND CONCLUDING REMARKS 
SUMMARY 
Cells polarize for a variety of diverse processes, and a central component of many 
polarized cells is the protein kinase atypical Protein Kinase C (aPKC), whose activity and 
localization are fundamental in establishing and maintaining discrete cortical domains.  
The regulation of aPKC activity must be tightly coupled to its localization such that it is 
only active while localized to the apical cortical domain, where it can exert its enzymatic 
activity to maintain the integrity of the apical domain through phosphorylation mediated 
cortical displacement.  While numerous protein-protein interactions are required for 
regulation of aPKC, none are sufficient to polarize aPKC’s activity.  As such, 
understanding how aPKC interacts with its regulators is paramount to determining the 
molecular mechanisms that govern aPKC polarization. 
The work presented here focused on the molecular interactions between Par-3 and 
the Par-complex that lead to regulation and complex formation.  The first part of my 
work focused on the interaction between the Par-3 APM and the aPKC kinase domain.  
Contrary to previous reports, I show that this interaction, like all enzyme/substrate 
interactions is transient and as such does not support a viable mechanism for a stable 
inhibited complex.  The second part of this work identified a novel, persistent interaction 
between the Par-complex and Par-3 that is independent of Par-3 phosphorylation, while 
showing that none of the other proposed interactions appear to be required for a stable 
persistent interaction (Figure 14).  Furthermore, for the first time, we have identified an 
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interaction between the Par-complex and Par-3 that abolishes aPKC’s apical polarization 
through a single point mutation in the aPKC PBM.  While this work has greatly improved 
our understanding of how Par-3 interacts with the Par-complex, a number of important 
questions still remain unanswered for us to understand the molecular mechanisms that 
underly aPKC’s regulation and apical polarization.  In the following section I will discuss 
some of these open questions and how answers to these questions will further our 
understanding of animal cell polarity.   
FUTURE CONSIDERATIONS 
Over two decades have passed since the initial discovery that aPKC interacts with 
Par-3.  While numerous interactions have been proposed to be required for complex 
assembly, controversy has surrounded nearly every one of these interactions.  
Furthermore, none of the previously identified interactions have been shown to be 
required in a cellular context.  With a much clearer picture of how Par-3 interacts with 
the Par-complex, we are poised to address a number of important outstanding questions: 
Figure 14: Par mediated animal cell polarization.  Par-3 interacts with the Par-complex 
through a persistent PDZ2-PBM interaction and a transient kinase-substrate interaction. 
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Does Par-3 regulate Par-complex activity (positively or negatively)?   How is the 
interaction between Par-3 and the Par-complex regulated?  What is the role of Par-3 
phosphorylation?  Why are both Par-3 and Cdc42 required for Par-complex polarization 
while neither are sufficient?  
The role of Par-3 as a regulator of aPKC activity 
Does Par-3 inhibit aPKC’s kinase activity?  The simple answer is, yes.  However, 
all substrates can inhibit kinase activity in vitro given the right conditions.  The more 
relevant question to ask is: Does the inhibition of aPKC by Par-3 have a functional 
consequence?  The easiest way to test this in vivo would be to remove the inhibitor and 
determine if the function of the kinase is affected.  However, Par-3 is required for 
aPKC’s apical polarization, and as such, aPKC is lost to the cytoplasm making this a little 
more difficult to assess directly.  However, a number of studies have been able to 
indirectly address this question in vivo.  For example, in epithelia over-expressing the 
phosphodead Par-3 mutant (S980A), while the apical membrane is deformed, aPKC still 
polarizes Lgl (Morais-de-Sá et al., 2010).  If Par-3 were acting as an inhibitor, Lgl would 
be cortical.  In the Drosophila central brain, over proliferation of neuroblasts is observed 
when fate determinants are cleared from the entire cortex leading to symmetric divisions.  
Over expression of an aPKC mutant that is targeted to the entire cortex leads to 
significant over proliferation.  While not as dramatic, over-expression of Par-3 in an 
otherwise WT background also leads to an increase in neuroblast numbers, further 
arguing against the Par-3 inhibitor model (Wirtz-Peitz et al., 2008).   
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More recently, Rodriguez et al showed that Par-3 can inhibit aPKC’s kinase 
activity using an in vivo reporter assay (Rodriguez et al., 2017).  While this experiment 
supports the in vitro inhibitor studies, it does not reconcile the role Par-3 has, if any, in 
regulating aPKC activity.  Therefore, it is still unclear if Par-3 inhibits aPKC activity.   
I have clearly demonstrated that the Par-3 APM is phosphorylated by the kinase 
domain of aPKC, nothing else needs to happen, and that it can competitively inhibit 
kinase activity as do all substrates.  If Par-3 inhibition has a functional consequence, it is 
possible that this could occur through an alternative mechanism.  I identified a novel Par-
3/aPKC interaction in chapter III between the PBM of aPKC and the PDZ2 of Par-3.  
Does this new interaction play a role in aPKC inhibition?  Maybe this interaction 
activates aPKC.  It is certainly plausible that this interaction serves no role in regulating 
aPKC activity.  Alternatively, the binding between Par-3 and aPKC outside of the APM 
may allow the APM to bind to the kinase domain better, or it may make the 
phosphorylated APM bind with higher affinity, blocking access to other substrates.  In 
the future we will be assessing the role the PDZ2 may play in regulating aPKC activity 
both in vitro and more importantly, in vivo. 
 
Cdc42 dissociates Par-3 from the Par-complex  
The dual requirement of Par-3 and Cdc42 on Par-complex polarization is 
controversial and numerous mechanisms have been hypothesized.  However, there is 
little consistency among models and conflicting data has made it difficult to agree upon 
one central model.  Recently, genetic studies suggest that Cdc42 and Par-3 are mutually 
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exclusive leading to two functionally distinct states: a Par-3/Par-6/aPKC inhibited 
complex and a Cdc42/Par-6/aPKC active complex (Rodriguez et al., 2017).   
 We have been investigating the mutual exclusivity of Par-3 and Cdc42.  While in 
vivo experiments have previously shown the two to be exclusive, early biochemical data 
showed that aPKC, Par-6, Par-3, and Cdc42 could form a quaternary complex (Joberty et 
al., 2000).  Whether or not these two observations are consistent is unclear.  Cdc42 binds 
to the semi-crib domain of Par-6, while Par-3 binds to the PBM of aPKC and as such 
cannot compete for the same binding site.  However, mutual exclusion could occur if the 
semi-crib and PBM were in close proximity to each other putting steric constraints on 
simultaneous binding.  If this were the case, then a quaternary complex could not be 
formed in vitro.  One explanation for the observed quaternary complex formation 
observed in vitro, is that this experiment was not done in the presence of ATP and as 
such, binding of the Par-3 APM to the aPKC kinase domain could remain bound as 
shown in chapter III.   
An alternative hypothesis is that Par-3 and Cdc42 compete for aPKC’s PBM 
where Cdc42 binding to the semi-crib increases the affinity of the Par-6 PDZ domain for 
the aPKC PBM.  In this model a quaternary complex could most certainly be observed in 
vitro, depending on the experimental conditions of the assay, while in vivo observations 
may not be able to capture this quaternary complex formation.  We are taking a 
systematic approach to 1) determine if the Par-complex switches from a Par-3 bound 
state and a Cdc42 bound state, and 2) to identify the mechanism that leads to these 
observed mutually exclusive states.  Preliminary biochemical studies show that Cdc42 
can indeed inhibit the binding interaction between Par-3 and the Par-complex, with the 
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reverse being true as well.  Furthermore, active Cdc42 is sufficient to dissociate the Par-3 
PDZ2 from the Par-complex (Figure 15).  
 While these preliminary experiments clearly show that Par-3 and Cdc42 can 
inhibit each other’s binding, it is still unclear whether this is through indirect competition 
for the aPKC PBM, or through direct competition resulting from steric constraints.  
Future studies will take a structure/function approach to discern these two models by first 
asking what minimal components of the Par-complex are required for Cdc42 mediated 
inhibition of Par-3 from the Par-complex.  For example, for this switching to occur, we 
Figure 15: Cdc42 inhibits the interaction between the Par-complex and the Par-3 PDZ2. 
(A) Cdc42 is sufficient to inhibit the interaction between Par-3 PDZ2 and the Par-complex  (B)
Indirect competition model where the aPKC PBM competes for Cdc42 bound Par-6 PDZ
domain and Par-3 PDZ2.
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know that the aPKC PBM and Par-3 PDZ2 domains are required.  The semi-crib domain 
is also required as this is the binding site for Cdc42.  Currently we are assessing the 
importance of the Par-6 PDZ through a mutation that disrupts its ability to bind PBM’s 
while maintaining a functional semi-crib.  If exclusion still occurs in the context of this 
mutant, then this would argue against the indirect competition model.  Regardless of the 
exact mechanism, the observation that Cdc42 is sufficient to dissociate Par-3 from the 
Par-complex is an exciting finding and, to the best of our knowledge, the first instance 
where the Par-3/Par-complex interaction is regulated. 
 
The role of Par-3 phosphorylation in animal cell polarity 
By far the most well characterized function of aPKC’s kinase activity is to restrict 
the localization of substrates like Miranda (Atwood and Prehoda, 2009), Numb (Wirtz-
Peitz et al., 2008), Lgl (Bailey and Prehoda, 2015; Betschinger et al., 2003), Par-1 (Hurov 
et al., 2004), and Par-2 (Hao et al., 2006) from localizing to the apical domain through 
phosphorylation mediated cortical displacement.  However, there is a smaller yet growing 
list of substrates whose activity is dependent on aPKC phosphorylation.  For example, the 
MAGUK protein, Dlg is required for proper alignment of the mitotic spindles during 
neuroblast asymmetric cell division (Siegrist and Doe, 2005).  Dlg’s guanylate kinase 
(GK) domain is auto-inhibited by its SH3 domain and access of the GK domain is 
required for its interactions with downstream spindle orientation factors like Guckholder 
(Johnston et al., 2009; Marcette et al., 2009).  Recently it was found that aPKC is 
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required for this interaction, where phosphorylation of Dlg’s SH3 domain by aPKC 
relieves auto-inhibition allowing it to bind Guckholder (Golub et al., 2017).   
Par-3 is another example of an aPKC substrate whose phosphorylation does not 
ascribe to the phosphorylation mediated cortical displacement model, at least in 
neuroblasts and the C. elegans embryo.  Interestingly, in epithelia, phosphorylation 
appears to signal its localization to adherens junctions where it interacts with the cadherin 
complex.  However, the role of phosphorylation appears to be important for interacting 
with members of the cadherin complex and not for cortical displacement as the phospho-
mimetic Par-3 still localizes to the membrane in neuroblasts (Morais-de-Sá et al., 2010).  
While previous mechanisms have described Par-3 phosphorylation as a regulatory 
mechanism that is required for the dissociation from the Par-complex, my data clearly 
shows that while phosphorylation inhibits the enzyme/substrate interactions, 
phosphorylation alone does not dissociate Par-3 from the fully reconstituted Par-complex.   
If phosphorylation is not a regulatory mechanism required for the dissociation of 
the complex, then what is the role of Par-3 phosphorylation.  Previous data has shown 
that constitutively active Cdc42 is sufficient to drive aPKC to the entire cortex, while 
Par-3 is still apically localized (Atwood et al., 2007).  One hypothesis is that 
phosphorylation of Par-3 is required for activating Cdc42, possibly through the 
recruitment of a GEF.  This mechanism would set up a strong positive feedback loop 
where initially, the Par-complex is recruited to the apical domain by Par-3, and that 
phosphorylation increases the local concentrations of a Cdc42 GEF, thus increasing the 
local concentration of activated Cdc42. 
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CONCLUDING REMARKS 
The work presented in this dissertation has contributed significantly to our 
understanding of the molecular interactions between three key components of the apical 
polarity network.  My work strongly supports a clear picture of how these three proteins 
interact.  aPKC phosphorylates Par-3 just like it phosphorylates all substrates: binding to 
the catalytic site followed by phosphate transfer and release.  Additionally, there is no 
genetic evidence to suggest a functional consequence to Par-3 inhibition of catalytic 
activity.  Furthermore, I show that phosphorylation alone is not sufficient to inhibit the 
Par-3/Par-complex interaction in a fully reconstituted system.  While further investigating 
the five previously reported molecular interactions between Par-3 and the Par-complex I 
uncovered a novel interaction between the PDZ2 domain of Par-3 and the COOH-
terminal PBM of aPKC that is not only biochemically required but also required for the 
polarization of aPKC in the Drosophila neuroblast.  Additionally, while we cannot rule 
out the possibility that none of the previously reported interactions are not contributing to 
these interactions, the PDZ2:PBM interaction is the only interaction that is required for 
complex formation.  Now that we understand how Par-3 and the Par-complex interact, we 
can investigate how these interactions are regulated.  Future work will seek to understand 
the role of Par-3 phosphorylation and what regulates the Par-3/Par-complex interaction 
focusing on the very interesting dual requirement of Par-3 and Cdc42 on aPKC apical 
polarization. 
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APPENDIX 
APPENDIX A: SUPPLEMENTAL MATERIALS FOR CHAPTER III 
Figure S1: Binding of Par-3 PDZ2 and aPKC PBM orthologues from diverse metazoan 
organisms and quantitative analysis by supernatant depletion.  Related to Figure 3.  (A) 
Solid phase (glutathione resin) bound to Glutathione-S-Transferase (GST) fused aPKC PBM’s 
with Par-3 PDZ2 domains from the indicated organisms (Dm = Drosophila melanogaster; Hs 
= Homo sapiens; Hv = Hydra vulgaris; Tr = Trichoplax sp H2).  Shaded region indicates 
fraction applied to gel (soluble phase or solid phase components after mixing with soluble 
phase components and washing).  (B) Equilibrium binding of Par-3 PDZ1-APM to Par-
6/aPKC (top panel) or Par-6/aPKC𝚫PBM (bottom panel).  Westerns show aPKC and Par-6 
remaining in the supernatant after incubation with solid phase (amylose resin) bound with the 
indicated concentration of Maltose Binding Protein (MBP) fused Par-3 PDZ1-APM.  Shaded 
region indicates fraction applied to gel after mixing and incubation.  
њ-aPKC
њ-Par-6
њ-aPKC
њ-Par-6
So
lid
ph
as
e
So
lu
bl
e
ph
as
e Par-6/
aPKC
[MBP-Par-3-PDZ1-APM] µM
So
lid
ph
as
e
So
lu
bl
e
ph
as
e Par-6/
aPKC
уPBM
0 0.08 0.17 0.34 0.68 1.35 2.70
[MBP-Par-3-PDZ1-APM] µM
0 0.08 0.17 0.34 0.68 1.35 2.70
So
lid
ph
as
eS
ol
ub
le
ph
as
e
GST
Dm Hs Hv Tr Dm Hs Hv Tr Dm Hs Hv Tr
Dm
PBM
Hs
PBM
Hv
PBM
Tr
PBM
Par-3 PDZ-2 Domains
A
B
 
 
 
66 
 
 
 
 
Figure S2 Recruitment of aPKC to the apical cortex of metaphase Drosophila 
neruoblasts depends on its PDZ Binding Motif.  Related to Figure 4.  (A) Protein 
localization in metaphase aPKCK06403 neuroblasts expressing WT or V606A aPKC.  The 
localization of HA-tagged WT or V606A aPKC, expressed using Worniu-GAL4/Uas, is 
shown with the basal marker Miranda, GFP-mCD8 (marks aPKCK06403 neuroblasts), and 
DNA (DAPI).  (B) Gardner-Altman estimation plot of effect of the aPKC V606A mutation on 
aPKC cortical localization.  Apical cortical to cytoplasmic signal anti-HA intensities are 
shown for individual aPKCK06403 metaphase neuroblasts expressing either HA-WT or HA-
V606A aPKC and for the anti-aPKC (includes endogenous and transgenically expressed).  
Statistics: Bootstrap 95% confidence interval (Bar in “V606A minus WT” column)  
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